Meeting Report

SECOND REGIONAL FORUM OF WHO
COLLABORATING CENTRES IN THE
WESTERN PACIFIC

28–29 November 2016
Manila, Philippines

Second Regional Forum of WHO Collaborating Centres in the Western Pacific28–29 November 2016
Manila, Philippines

WORLD HEALTH ORGANIZATIONREGIONAL OFFICE FOR THE WESTERN PACIFIC
RS/2016/GE/39(PHL)

English only

MEETING REPORTREPORT OF THE SECOND REGIONAL FORUM OF
WHO COLLABORATING CENTRES IN THE WESTERN PACIFIC

Convened by:WORLD HEALTH ORGANIZATIONREGIONAL OFFICE FOR THE WESTERN PACIFIC

Manila, Philippines
28–29 November 2016

Not for sale
Printed and distributed by:World Health Organization
Regional Office for the Western Pacific
Manila, Philippines
July 2017

NOTE
The views expressed in this report are those of the participants of the Second Regional
Forum of WHO Collaborating Centres in the Western Pacific and do not necessarilyreflect the policies of the conveners.

This report has been prepared by the World Health Organization Regional Office for theWestern Pacific for Member States in the Region and for those who participated in theSecond Regional Forum of WHO Collaborating Centres in the Western Pacific in
Manila, Philippines from 28 to 29 November 2016.

CONTENTS
Page
SUMMARY .......................................................................................................................... 1
INTRODUCTION ................................................................................................................. 2
1.1 Background ................................................................................................................... 2
1.2 Forum objectives .......................................................................................................... 2
1.3 Forum organization....................................................................................................... 2
1.4 Participants ................................................................................................................... 2
2. PROCEEDINGS ...................................................................................................................... 3
2.1 Opening session ............................................................................................................ 3
2.2 Plenary session 1: Taking stock – Identifying opportunities, implementation
challenges and good practices in networking and partnerships .................................... 3
2.3 Plenary session 2: Transforming our world – The 2030 Agenda for
Sustainable Development ............................................................................................. 4
2.4 Parallel sessions 1: Technical sessions (part one) – Supporting Member Statesto achieve the SDGs...................................................................................................... 5
2.5 Plenary session 3: Aligning the work of WHO Collaborating Centres to the needsof Member States .......................................................................................................... 5
2.6 Parallel sessions 2: Cross-cutting thematic group discussions ..................................... 6
2.7 Parallel sessions 3: Cross-cutting operational group discussions –Improving effectiveness of work in countries .............................................................. 7
2.8 Parallel sessions 4: Technical session (part two) – Supporting Member Statesto achieve the SDGs...................................................................................................... 8
2.9 Lunchtime seminars: Overview of policies and procedures related to
WHO collaborating centres .......................................................................................... 8
2.10 Plenary session 4........................................................................................................... 8
3. CONCLUSIONS ...................................................................................................................... 9
ANNEXES:ANNEX 1 - MEETING PROGRAMME ...................................................................... 13
ANNEX 2 - LIST OF PARTICIPANTS, OBSERVERS AND SECRETARIAT ........ 15
ANNEX 3 - OUTCOMES OF PARALLEL SESSIONS .............................................. 29
ANNEX 4 - LIST OF POSTERS PRESENTED........................................................... 53

Keywords:

Intersectoral collaboration / International cooperation / Technical cooperation

SUMMARY
World Health Organization (WHO) collaborating centres in 10 Member States in the Western
Pacific Region are indispensable partners in advancing WHO technical work. WHO collaborating
centres provide strategic support to the Organization to meet two main needs: implementing
WHO's mandated work and programme objectives, and developing and strengthening
institutional capacity in countries and regions.
The Second Regional Forum of WHO Collaborating Centres in the Western Pacific, held in
Manila, Philippines on 28-29 November 2016, was designed to promote partnerships in the
Sustainable Development Goals (SDGs) era, building on the gains from the first Forum held in
November 2014.
The Forum offered WHO and WHO collaborating centres an opportunity to consider
multidisciplinary, interprofessional approaches to collaboration, leading to recommendations andactions to improve the quality of WHO collaborating centre work plans. The Forum also enabled
WHO collaborating centres to better understand their key role in amplifying WHO efforts toachieve the SDGs vision of universally shared and common progress towards the goals andtargets reflecting that no one and no country should be left behind in balanced and sustainable
development.
A total of 214 representatives from 143 collaborating centres attended, including fivecollaborating centres that participated via videoconference. The Forum's technical sessions werecomplemented by working sessions that explored cross-cutting themes and operations that
contribute to greater effectiveness in countries. The Forum concluded with remarks by the WHO
Regional Director and endorsement of the 2016 Outcome Statement by the participating centres
and WHO Secretariat.

1. INTRODUCTION
1.1

Background

World Health Organization (WHO) collaborating centres provide strategic support to theOrganization to implement its mandated work and programme objectives, and to strengthen
institutional capacity in countries and regions. Designation as a WHO collaborating centre offers
institutions heightened visibility for their work and enables them to extend their networks andtechnical cooperation with other institutions and mobilize resources from funding partners. In aneffort to build more effective and accountable partnerships with WHO collaborating centres, the
WHO Regional Office for the Western Pacific convened the First Regional Forum of WHO
Collaborating Centres in the Western Pacific in 2014.
The WHO Regional Office convened the Second Regional Forum to stimulate new approaches tocollaboration for accelerated achievement of the Sustainable Development Goals (SDGs) in
Member States, including universal health coverage, so that no one is left behind. This goal willremain a core focus of WHO’s work with Member States in the SDG era. WHO collaborating
centres can play a key role in these efforts.
1.2

Forum objectives

The objectives of the Forum were:(1)
to promote, report and share successful progress since the first Forum by identifying
opportunities, implementation challenges and good practices, and using these towards
promoting better implementation, reporting, networking and communication;(2)
to propose innovative collaboration mechanisms to support the achievement of theSDGs through universal health coverage, using multidisciplinary, interprofessional
approaches to existing and emerging challenges; and(3)
to discuss how to improve alignment of WHO collaborating centres' support
activities with the needs and priorities of Member States.
1.3

Forum organization

The Forum was convened by the WHO Regional Office for the Western Pacific. The meeting
agenda and detailed programme are available in Annex 1.
1.4

Participants

A total of 214 representatives from 143 collaborating centres attended, including fivecollaborating centres that participated via videoconference. The WHO Secretariat wasrepresented by the Regional Director, directors of the technical and administrative divisions, thecore organizing committee, and the WHO responsible technical officers for the collaborating
centres. A list of participants is available in Annex 2.

2

2. PROCEEDINGS

2.1

Opening session

In his opening address, Dr Shin Young-soo, WHO Regional Director for the Western Pacific,
outlined regional health and development gains realized since the first Forum, held in 2014. He
acknowledged the collaborative efforts that had contributed to progress and noted the challenges
that threaten some of the Region's most celebrated health gains.
Dr Shin summarized the priorities set by the WHO Regional Committee in 2015 and 2016 to
inform the work of WHO and its collaborating partners. This broad and substantial agenda
includes communicable diseases such as viral hepatitis, tuberculosis (TB), malaria and dengue, as
well as broader public health challenges such as injuries and violence, urbanization, health andthe environment, and health systems strengthening, in the context of the SDGs, including theuniversal health coverage (UHC) target. In this context, Dr Shin highlighted the updated Asia
Pacific Strategy for Emerging Diseases and Public Health Emergencies (APSED III), which
promotes multi-source information for evidence-based risk assessment, integrated management
systems and emergency operation centres. APSED III maintains its emphasis on the core system,
while emphasizing the broader health system context and links with the SDGs. Dr Shin referred
to progress made and lessons learnt from recent disease outbreaks and natural disasters in the
Region, including the Middle East respiratory syndrome in the Republic of Korea, circulating
vaccine-derived poliovirus in the Lao People’s Democratic Republic, and tropical cyclone
Winston, the most powerful storm on record to make landfall in the southern hemisphere.
In closing, Dr Shin recognized the importance of effective partnerships in extending WHO’sreach and responsiveness to the Region’s priority public health challenges. He called for further
strengthening of partnerships to effectively support countries to accelerate achievement of theSDGs, an agenda with important implications for ways of working in WHO and Member Statesalike.
2.2

Plenary session 1: Taking stock – Identifying opportunities, implementation challenges andgood practices in networking and partnerships

This session enabled participants to share and reflect on the valuable work undertaken in the
Region since the last Forum. WHO collaborating centres presented three case studies illustrating
the value of collaboration in improving the effectiveness and relevance of technical support forthe priority needs of Member States.
First, Dr Masato Kasuga, National Centre for Global Medicine, Japan (WHO Collaborating
Centre for Health Systems Research and WHO Collaborating Centre for Health Development andRelated Technical Cooperation) presented on the centre’s work to improve health workforce
quality in Cambodia and the Lao People’s Democratic Republic by strengthening the foundationsof the health workforce regulatory framework in both countries.
Next, Dr Sangjin Park, National Institute of Food and Drug Safety Evaluation of the Ministry ofFood and Drug Safety, the Republic of Korea (WHO Collaborating Centre for Standardizationand Evaluation of Biologicals) presented on the partnership between WHO and the Ministry ofFood and Drug Safety to support Member States in regulating biomedical products. Ministry
experts worked with governments in Cambodia, Mongolia and the Philippines to support national
regulatory authority assessments.
Lastly, Dr Samuel Yeung, Centre for Food Safety, Food and Environmental Hygiene
Department, Hong Kong SAR (China) (WHO Collaborating Centre for Risk Analysis of3

Chemicals in Food) presented a case illustrating the benefit of cross-centre collaboration and new
ways of working.
In the discussions that followed, participants shared other examples of success based on strong
partnerships and stressed the importance of close working relationships.
2.3

Plenary session 2: Transforming our world – The 2030 Agenda for Sustainable
Development

At the sixty-seventh session of the WHO Regional Committee for the Western Pacific in October
2016, Member States endorsed the Regional Action Agenda on Achieving the Sustainable
Development Goals in the Western Pacific.
Through a panel moderated by Dr Takeshi Kasai, Director, Programme Management, andconsisting of directors of the Regional Office technical divisions, this session enabled participants
to better understand the implications of the SDGs for WHO, its partners and Member States.
Dr Vivian Lin, Director, Health Systems, reflected on the progress made towards the Millennium
Development Goals (MDGs) and the challenge of persistent health inequities in moving from the
MDGs to the SDGs. Health is influenced by, and in turn influences, all the SDGs. UHC is aseparate SDG target and also provides a unifying platform that brings together efforts acrosshealth programmes. Given their interconnected and indivisible nature, achieving the SDGs whileleaving no one behind requires working across the whole health system and across sectors andstakeholders. This implies new roles for the health sector in the SDG era, including that of
informing, influencing and institutionalizing action. WHO’s initial support to countries focuseson country reporting and regional monitoring of progress towards UHC and other SDG targets, aswell as integrating an equity focus into health programmes.
Dr Mark Jacobs, Director, Communicable Diseases, explained that communicable diseases had
been a major focus of the MDGs and remain an explicit focus of the SDGs. He used examples toillustrate how communicable diseases are also implicitly closely linked to several other SDGs. In
some cases, communicable diseases contribute to SDG achievement; in others, the SDG or target(addressing a given social determinant of health) contributes to communicable disease control.
Current communicable disease control priorities include ensuring sustainable financing,developing integrated regional frameworks for priority communicable diseases, and working
across programmes to achieve elimination goals.
Dr Susan Mercado, Director, NCD and Health through the Life-Course, explained how the SDGs
will enable people to take control of their lives and health through the various targets that address
underlying causes of poor health, specifically those related to the environment. WHO’s DPSEEA
model (comprising a chain ranging from driving forces, to pressures, state, exposures, healtheffects and actions) illustrates the importance of acting on the upstream determinants of health toimprove population health. The SDGs have repositioned health promotion in the context ofglobal health; the 9th Global Conference on Health Promotion held in Shanghai in November
2016 had the theme “Health Promotion in the SDGs”. Dr Mercado stressed that multisectoral
action will be the new norm in the SDG era.
Reiterating the interrelated and interconnected nature of the SDGs, Dr Li Ailan, Director, Health
Security and Emergencies, explained that strengthening national capacities for early warning,disaster risk reduction and management of national and global health risks affects, and is in turnaffected by, a range of sectors and issues. Success can only be achieved using a systems
approach. She presented on APSED III, food safety and disaster risk management as key
examples of investments in achieving sustainable development.

4

2.4

Parallel sessions 1: Technical sessions (part one) – Supporting Member Statesto achieve the SDGs

In 20 parallel technical sessions facilitated by WHO technical officers, WHO collaborating
centres and WHO responsible officers discussed their activities and priorities, took stock ofprogress in implementing the 2014 Forum recommendations, and explored the links between
SDGs and their respective programme areas. A summary of the outcomes of these sessions isavailable in Annex 3.
2.5

Plenary session 3: Aligning the work of WHO collaborating centres to the needsof Member States

This session was moderated by Prof Regina Lee, Associate Professor and Deputy Director,
School of Nursing, Hong Kong Polytechnic University (WHO Collaborating Centre forCommunity Health Services). The session aimed to identify ways to bring the expertise of WHO
collaborating centres into WHO’s country support initiatives. It sought to motivate them to think
and work beyond national/technical boundaries and to work with WHO in proactively supporting
Member States. The session comprised three case studies, presented jointly by WHO
representatives, WHO collaborating centres and WHO Regional Office focal points, illustrating
examples of successful collaboration on support to countries.
The first presentation related to support for emerging infectious diseases in Viet Nam and waspresented by Dr Lokky Wai, WHO Representative in Viet Nam (by videoconference), Dr
Kouichi Morita, Nagasaki University (WHO Collaborating Centre for Reference and Research on
Tropical and Emerging Virus Disease) and Dr Frank Konings, Acting Medical Officer forInternational Health Regulations and Technical Officer for Laboratory, WHO Regional Office for
the Western Pacific.
The second presentation related to early essential newborn care in the Lao People’s Democratic
Republic, and was presented by Dr Juliet Fleischl, WHO Representative in the Lao People’s
Democratic Republic (by videoconference), Dr Kim Mulholland, Centre for International Child
Health (WHO Collaborating Centre for Research and Training in Child and Neonatal Health) andDr Howard Sobel, Coordinator, Reproductive, Maternal, Newborn, Child and Adolescent Health,
WHO Regional Office for the Western Pacific.
The third presentation related to a Diploma in Medical Laboratory Science in the Pacific, and waspresented by Dr Corinne Capuano, Director, Pacific Technical Support and WHO Representativein the South Pacific (by videoconference), Mr Philip Wakem and Mr Navin Karan, PacificParamedical Training Centre (WHO Collaborating Centre for External Quality Assessment in
Health Laboratory Services) and Ms Elaine O’Leary, Technical Officer: Capacity-building,
WHO Regional Office for the Western Pacific.
The presentations highlighted good practices of WHO collaborating centres in providing country
support, based on sound understanding of country contexts, priorities and stakeholders, thebuilding of rapport with national counterparts, and sustained engagement, including throughreview and evaluation. Each case illustrated successful team approaches between WHO country
offices, the Regional Office and WHO collaborating centres, enabling the centres to directly
contribute to advancing WHO priorities at country and regional levels. WHO collaborating
centres interested in expanding their Member State support role were encouraged to liaise with
their WHO responsible technical officer as a first point of contact.

5

2.6

Parallel sessions 2: Cross-cutting thematic group discussions

The cross-cutting thematic group discussions gave participants the opportunity to understand how
various cross-cutting issues intersect with and contribute to WHO and Member State priorities.
WHO collaborating centres considered ways to incorporate these issues into their current andfuture work plans, for greater effectiveness at the country level. A summary of the outcomes ofthese parallel sessions is available in Annex 3.
2.6.1 Health promotion in the age of urbanization and ageing
In this session, participants discussed how health promotion action works towards improving theconditions of daily life by building healthy public policies, creating supportive environments,
strengthening community action, developing personal skills and reorienting health services. They
identified ways in which health promotion frameworks can strengthen technical support tocountries.
2.6.2
Achieving UHC: a synergized action addressing equity, quality, efficiency and financial
protection
WHO defines UHC as all people having access to quality health services without suffering thefinancial hardship associated with paying for care. UHC is the overarching vision for healthsector development and a key target in SDG 3. This session offered the opportunity to better
understand UHC in the context of the SDGs and identified ways in which WHO collaborating
centres can support the WHO Regional Office in advancing UHC. UHC work follows theregional action framework Universal Health Coverage: Moving Towards Better Health, endorsedby the Regional Committee in 2015.
2.6.3
Health security, including public health preparedness and response to emergencies anddisasters
The Western Pacific Region is vulnerable to health security and emergency risks. WHO’s Health
Emergencies Programme aims to help countries prepare for, prevent, respond to and recover fromemergencies quickly, in a more predictable, dependable and accountable way, whether these arecaused by disease outbreaks, disasters or conflict. This session explored options for country
support to address public health preparedness and response to emergencies and disasters, andexplored the collaboration needed beyond technical boundaries.
2.6.4

Tackling the social roots of health inequities

Health equity is described as the absence of unfair and avoidable or remediable differences inhealth among social groups. The SDGs have a strong focus on equity and human rights, informedby the social determinants of health. The integration of equity, human rights, gender equity andthe social determinants of health into WHO policies, programmes and institutional mechanisms isvital in leaving no one behind, a core principle of the SDGs. Participants in this session discussed
the links between equity and current work plans in the context of UHC and the SDGs, policies
and actions that can help reduce health inequities, and ways to measure performance on healthequity.
2.6.5

Public health law: effective use of legislation to support public health policy objectives

Law is a powerful policy tool that can improve health outcomes and the achievement of theSDGs in many ways. However, it can be difficult to use effectively. Laws are often developed
without regard to existing evidence and expertise, and not effectively implemented or enforced.
Laws can be poorly designed and ineffective in supporting the underlying policy objective or6

have unintended impacts that are harmful to population health. This session considered thechallenges in the effective use of legislation and provided an opportunity for WHO collaborating
centres to discuss and share their experiences and lessons learnt in the development,
implementation and/or review of legislation as it relates to their areas of work.
2.6.6

Antimicrobial resistance: need for a global response

Antimicrobial resistance (AMR) is a complex problem that affects all of society and is driven by
many interconnected factors. Single, isolated interventions have limited impact. Coordinatedaction is required to minimize its emergence and spread. This session examined AMR in thecontext of the SDGs and provided an overview of WHO’s work at the global, regional andnational levels to support countries in developing and implementing national AMR action plans.
2.7

Parallel sessions 3: Cross-cutting operational group discussions – Improving effectivenessof work in countries

These parallel sessions were designed to increase understanding of the factors that can strengthen
the effectiveness of WHO collaborating centre activities in countries. WHO collaborating centres
had identified the issues discussed in these sessions in a pre-Forum survey. A summary of theoutcomes of these parallel sessions is available in Annex 3. These outcomes and those from thethematic discussions in Parallel Sessions 2 fed into discussions during the second round oftechnical sessions on enhancing the effectiveness of current work plans and the design of future
work plans.
2.7.1

Research to support country needs

Participants in this session considered how to improve the relevance and application of researchin countries. Research is essential for fostering innovation and promoting development. Researchshould go beyond publication to inform policy development and improve health outcomes. It canplay an important role in informing policy development, health interventions and education andtraining. Building evidence-based sustainable institutional capacity is one of WHO’s corefunctions. WHO depends on many partners such as WHO collaborating centres to generate
evidence. WHO and its research partners are duty-bound to ensure that this evidence istransparent, complete, and free of perceived or real conflicts of interest, and provided in a waythat is most useful for Member States.
2.7.2

Training for impact at country level

In this session, participants discussed the potential of training in health workforce capacity
development. Training can help develop health workforce capacity in countries, when it isdesigned and implemented using a systems approach. This approach takes into account thecountry, institution, health and education, and existing workforce contexts, and assesses theorganisation’s and country’s readiness for training. Assessment of training effectiveness is often
limited to participants’ feedback. Good training is an important starting point, but complementarypolicies and actions are needed to increase the likelihood of behavioural change and applicationof the new skills learnt.
2.7.3

Communicating for better results

In this session, participants discussed key aspects of communications and how it may be used toincrease the effectiveness of collaboration and activities in countries. Communications can be a
powerful tool for improving the effectiveness of activities. It can build support for healthdevelopment, promote advocates for reform, galvanize support and encourage more informed
decision-making at all levels. Communications should therefore be an integral part of theplanning of any initiative, rather than a process that is undertaken at the end of an activity.

7

2.8

Parallel sessions 4: Technical session (part two) – Supporting Member Statesto achieve the SDGs

These sessions brought WHO collaborating centres and WHO technical officers back together toreflect on outcomes from the previous cross-cutting sessions and plenaries. Participants discussed
strategies to strengthen collaboration and identified options for enhancing existing work plans tobetter support Member States in achieving the SDGs. A summary of the outcomes of the paralleltechnical sessions is available in Annex 3.
2.9

Lunchtime seminars: Overview of policies and procedures related to
WHO collaborating centres

These sessions, facilitated by Mr Matias Tuler, Programme Officer, Policy and Information,
WHO headquarters, and Dr Rasul Baghirov, Coordinator, Integrated Service Delivery, WHO
Regional Office for the Western Pacific, were held during lunch breaks, to update participants onpolicies and procedures related to WHO collaborating centres and to answer questions on
different aspects of designation and redesignation. The sessions were well attended and attracted
interest from participants.
2.10 Plenary session 4
In the final plenary session, the highlights of the discussions in preceding sessions weresummarized as follows:– Health promotion action works towards improving the conditions of daily life. It is acost-effective way for Member States to improve public health and reduce theeconomic costs of illness.
– UHC is the overarching vision for health sector development and is critical tosustainable development. As the pathway to achieving the SDGs, UHC requires actions
to strengthen the health system attributes of quality, efficiency, equity, accountability
and governance, and sustainability and resilience.
– Cross-boundary technical collaboration can improve the effectiveness of country
support to address public health preparedness and response to emergencies anddisasters.
– The integration of equity, human rights, gender and social determinants into WHO
policies, programmes and institutional mechanisms is key to the core SDG principle ofleaving no one behind.
– Public health law is a powerful policy tool that can support improved health outcomes
and the achievement of the SDGs if based on existing evidence and expertise andeffectively implemented and enforced. Coordinated action is required to minimize theemergence and spread of AMR.
– WHO-led training is best embedded in a health systems approach. The objectives of the
training should go beyond merely transferring knowledge to also include practicaloutcomes and ongoing mentoring. Training should be recognized as a long-term
investment.
– Research objectives and outcomes need to be discussed with end users to ensure
relevance and timeliness for Member States, with WHO collaborating centres playing a8

bigger role in building evidence and information systems and engaging in country-levelmonitoring and evaluation of strategies and plans.
– Before communication products are developed, the target audience(s) must be
identified.
– WHO collaborating centres and WHO should have regular teleconferences and increase
regular and mutual sharing and translation of strategies, documents, tools and resources.
WHO should continue to guide the WHO collaborating centres on evolving priorities inMember States.
On partnership:– WHO can build on the technical strengths of WHO collaborating centres to enhancecountry support in technical priority areas. WHO collaborating centres should explore
increasing direct collaboration with and support of Member States.
– WHO collaborating centres should be mindful of commercial interests and industry
engagement and how these might affect the collaboration with WHO.
– WHO collaborating centres can work more closely with WHO by being better aware of
WHO norms and standards and the contexts in Member States.
– Collaboration can be strengthened between WHO and WHO collaborating centres andbetween collaborating centres (e.g. joint activities) and networks built with otherpartners, institutions and experts.
– WHO collaborating centres should broaden their focus areas (through a public health,whole-of-systems perspective) and align better with UHC and the SDGs, including
through multidisciplinary approaches.
The session also discussed and adopted the Forum’s Outcome Statement.

3. CONCLUSIONS

Conclusions
Forum participants acknowledged the importance of working across the whole health system, as
well as across sectors and stakeholders, to achieve the vision of the SDGs. They committed tostrengthening collaboration between WHO collaborating centres, WHO and Member States
through their delivery of programme work plans, focusing on impact, equity and sustainability to
improve the effectiveness of work in and across Member States.
Participants agreed on an Outcome Statement that recognized the profound implications of theSDGs for WHO, Member States and partners, in terms of new ways of working and new
partnerships. The Statement emphasized that collaborative cross-programmatic and cross-sectoral
action for health is paramount for balanced, equitable and sustainable development that leaves noone behind.

9Consistent with agreed terms of reference and work plans, participants at the Forum agreed to:– continue to foster active, innovative and effective partnerships for better health incountries;– ensure that collaboration is designed, implemented and communicated in line withMember State priorities and commitments to achieving the SDGs;– support collaboration between WHO collaborating centres working across technicalareas and WHO regions to facilitate optimum outcomes for countries;– promote, report and share progress and good practice with WHO, other WHO
collaborating centres and Member States using the most effective modes ofcommunication; and– reconvene in 2018 to review the outcomes of the partnership of WHO and WHO
collaborating centres consistent with SDG priorities in countries.

10

OUTCOME STATEMENT OF THE SECOND REGIONAL FORUM OF
WHO COLLABORATING CENTRES IN THE WESTERN PACIFIC
Preamble
The Second WHO Regional Forum of WHO Collaborating Centres in the Western Pacificwas significant in its timing and relevance, being held in the first year of the new era of the
Sustainable Development Goals (SDGs).
The adoption of the SDGs by world leaders in September 2015 signalled the commitmentof governments to work across sectors, the integration of health programmes, reachingpopulations in need, and ensuring that no one suffers undue financial hardship in accessing
health services. In taking the lead on the SDG agenda, Member States of the Western
Pacific Region have endorsed Universal Health Coverage: Moving Towards Better Healthand the Regional Action Agenda on Achieving the Sustainable Development Goals in theWestern Pacific. At the core of this regional action framework for health systemstrengthening are five attributes: quality, efficiency, equity, accountability, and resilienceand sustainability. In this context, countries have asked WHO for assistance in tackling an
ambitious development agenda over the next 15 years.
The SDG era has profound implications for new ways of working and new partnerships.
This Forum has discussed and identified the extended value, reach and expertise that the
WHO collaborating centres offer WHO to promote its work in countries, regionally andglobally.
We, the representatives of the WHO collaborating centres in the Western Pacific Region
and the WHO Secretariat, participating in the Second Regional Forum of the WHO
Collaborating Centres in the Western Pacific, organized in Manila in November 2016,
Acknowledge that
Since the first Forum, considerable progress has been made in strengthening collaborativeand strategic partnerships between WHO and WHO collaborating centres towards
improving health at the country and regional levels.
Reaffirm that
WHO collaborating centres play a key role in amplifying WHO efforts to support Member
States to achieve shared and common progress towards the SDGs.
Emphasize that
Collaborative cross-programmatic and cross-sectoral action for health is paramount for theagenda of balanced, equitable and sustainable development, calling to leave no one
behind.
Remain convinced that
Effectiveness of work in and across countries can be strengthened through collaborations
that focus on impact, equity and sustainability.

11

Agree toConsistent with agreed terms of reference and work plans:
•
•
•
•
•

Continue to foster active, innovative and effective partnerships for better health incountries.
Ensure that collaboration is designed, implemented and communicated in line withMember State priorities and commitments to achieving the SDGs.
Support collaboration between WHO collaborating centres working across technicalareas and WHO regions to facilitate optimum outcomes for countries.
Promote, report and share progress and good practice with WHO, other WHO
collaborating centres and Member States, using the most effective modes ofcommunication.
Reconvene in 2018 to review the outcomes of the partnership of WHO and WHO
collaborating centres consistent with the SDG priorities in countries

12

ANNEX 1

FULL PROGRAMMETime

Day 1: Monday, 28 November 2016

08:30

Opening session - Conference Hallx Welcome by Dr Takeshi Kasai – WHO Director of Programme Management, WHO Regional Office for the Western Pacificx Introduction of Forum participantsx Keynote speech - Dr Shin Young-soo – WHO Regional Director for the Western PacificGroup photo on the Lawn
Mobility break - Upper and lower conference hall lounge and Al Fresco
Plenary session 1 – Conference Hall
Taking stock: Identifying opportunities, implementation challenges and good practices in networking and partnerships
x Report from the Secretariat – Dr Takeshi Kasai, WHO Director of Programme Management, WHO Regional Office for the Western Pacificx Experiences working through effective partnerships and collaboration:
1. National Centre for Global Medicine (NCGM)- Japan - WHO Collaborating Centre for Health Systems Research
2. National Institute of Food and Drug Safety Evaluation (NIFDS) of Ministry of Food and Drug Safety (MFDS)- the Republic of Korea – WHO Collaborating Centre for Standardization and Evaluation of Biologicals
3. Centre for Food Safety, Food and Environmental Hygiene Department, Hong Kong SAR (China) - WHO Collaborating Centre for Risk Analysis of Chemicals in Food

10:00
10:20
10:50

11:50

Lunch
Cafeteria and Alfresco

Poster Session 1 (12.45-13.30)
Conference Hall upper and lower lounge and foyer

13:45

Plenary session 2 – Conference Hall
Transforming our world – the 2030 Agenda for Sustainable Development – panel session
x Dr Vivian Lin, Director, Health Systems
x Dr Mark Jacobs, Director, Communicable Diseases
x Dr Susan Mercado, Director, NCD and Health through the Life-course
x Dr Li Ailan, Director, Health Security and Emergencies

Day 1 Seminar - Conference Hall (12.45-13.30)
Overview on policies and procedures related to WHO collaborating centres
Facilitators: Matias Tuler and Rasul Baghirov

14:45
Parallel sessions 1: Technical session for WHO CCs by themes
Malaria, other
Tuberculosis
HIV/AIDS, hepatitis
Mobility vector-borne andand sexual
break
transmitted
neglected tropical
Lead: Nobuyuki
15:45infectiondiseases
Nishikiori
16:15,
Room: 404
various
Lead: Rabindra
Lead: Ying-Ru Lo
locations Abeyasinghe
Room: 409-D
Room: 421
Health research
ethics and law
Lead: Ki Hyun
Hahm and Luke
Elich
Room: 406-E
17:30
18:00

Essential
medicines, healthtechnology andbiologicals
Lead: David Newby
Room: 210-A

Health informationand e-health
Lead: Gao Jun
Room: 310 Bluewave

Noncommunicablediseases

Health promotion

Healthy diet andoral healthTobacco Free
Initiative

Mental health andsubstance abuse

Lead: Hai-Rim Shin
Room: 212

Lead: Tara
Kessaram
Room: 212

Lead: Katrin
Engelhardt
Room: 212

Lead: Katia De
Pinho Campos
Room: 212

Lead: Xiao Sobel
Room: 402

Traditional
medicine

Disability andrehabilitation
Lead: Darryl Barrett
Room: 210-B

Service delivery and Health workforce
financing
Lead: Indrajit
Hazarika
Lead: Rasul
Baghirov and Xu Ke Room: 414-A Cake
Room: 208-E

Transport to the Regional Director's Reception
Regional Director's Reception – Manila Ballroom of Manila Hotel13

Lead: Yu Lee Park
Room: 321

Reproductive,
maternal, neonatal,child andadolescent healthInternational
Health Regulations:emerging diseases
and food safety

Lead: Howard Sobel
Room: 410 Pizza

Lead: Peter
HoejskovRoom: 403 EOC

Environmental
healthOccupational
healthLibrary andpublications

Lead: Rifat Hossain
Room: 313-S

Lead: Nasir Hassan
Room: 314 Narra

Lead: Marie
Villemin-Partow
Room: LibraryTime

Day 2: Tuesday, 29 November 2016

08:30

Plenary session 3 – Conference Hall
Aligning the work of WHO collaborating centres to the needs of Member Statesx Nagasaki University – emerging infectious diseases in Japanx Pacific Paramedical Training Centre – blended learning and course accreditationx Centre for International Child Health – coaching in Early Essential Newborn Care

9:30
10:00

Mobility break - Upper and lower conference hall lounge and Al Fresco

11:00
11:15

Parallel sessions 2 – cross-cutting thematic group discussions
Health promotion
Universal health coverage

Health security

Addressing health inequities

Public health law

Antimicrobial resistance

Lead: Hai-Rim Shin
Room: Conference Hall

Lead: Frank Konnings
Room: 210

Leads: Anjana Bhushan, Britta
Baer
Room: 208-E

Leads: Luke Elich, Ki-Hyun Hahm
Room: 410 Pizza

Leads: Sarah Paulin, Babatunde
Olowokure
Room: 414-A Cake

Leads: Xu Ke and Rasul Baghirov
Room: 212

Move to meeting rooms for Parallel Sessions 3
Parallel sessions 3 – cross-cutting operational group discussions
Research to support country needs

12:15

Group 1 lead:
Jun Gao and David Newby
Room: 410 Pizza
Lunch
Cafeteria and Alfresco

Training for impact at country level

Group 2 lead:Group 1 lead:
Nobuyuki Nishikiori
Elaine O’Leary
Room: 414-A Cake
Room: 212
Poster Session 2 (13:00 – 13:45)
Conference hall upper and lower lounge and foyer

Communicating for better resultsGroup 2 lead:Group 1 lead:
Howard Sobel
Angela Pratt
Room: 210
Room: 208-E
Day 2 Seminar - Conference Hall (13:00 – 13:45)
Overview on policies and procedures related to WHO collaborating centres
Facilitators: Matias Tuler and Rasul Baghirov

Group 2 lead:
Eloi Yao+02
Room: 403 EOC

14:00
Parallel sessions 4 – technical groupings – Supporting Member States to achieve the SDGs
Malaria, other
Tuberculosis
HIV/AIDS, hepatitis Noncommunicable
Health promotion
vector-borne andand sexual
diseasestransmitted
neglected tropical
Lead: Nobuyuki
infectiondiseases
Lead: Hai-Rim Shin
Lead: Tara Kessaram
Nishikiori
Room: 212
Room: 212
Room: 404
Lead: Rabindra
Lead: Ying-Ru Lo
Abeyasinghe
Room: 409-D
Room: 421
Health research
ethics and law
Lead: Ki Hyun
Hahm, Luke Elich
Room: 406-E
15:00
15:30 17:00

Essential
medicines, healthtechnology andbiologicals

Health informationand e-healthService delivery andfinancing

Lead: Gao Jun
Room: 310-Blue
Wave

Lead: Rasul Baghirov
and Xu Ke
Room: 208-E

Health workforce

Healthy diet andoral healthTobacco Free
Initiative

Mental health andsubstance abuse

Lead: Katrin
Engelhardt
Room: 212

Lead: Katia De Pinho
CamposRoom: 212

Lead: Xiao Sobel
Room: 402

Traditional
medicine

Lead: Indrajit
Hazarika
Room: 414-A Cake

Lead: Yu Lee Park
Room: 321

Lead: David Newby
Room: 210-A
Mobility break - Upper and lower conference hall lounge and Al Fresco
Plenary session 4 – Conference Hall
x Report back from parallel sessions on key highlights and way forward
Closing session
x Closing remarks - Dr Shin Young-soo – WHO Regional Director for the Western Pacific

14

Disability andrehabilitation
Lead: Darryl Barrett
Room: 210-B

Reproductive,
maternal, neonatal,child andadolescent health
Lead: Howard
Sobel
Room: 410 Pizza

Environmental
healthOccupational
healthLead: Rifat Hossain
Room: 313-S

Lead: Nasir Hassan
Room: 314 Narra

International
HealthRegulations:emerging diseases
and food safety
Lead: Peter
HoejskovRoom: 403 EOC
Library andpublications
Lead: Marie
Villemin-Partow
Room: LibraryANNEX 2
PARTICIPANTS
Reference
numberName of Institution

AUS-45National Serology Reference
Laboratory, St. Vincent’s
Institute of Medical Research

AUS-59The Centre for Eye Research
Australia, Royal Victorian Eyeand Ear Hospital
School of Life Sciences,
Queensland University ofTechnology
Centre for Health Equity, Schoolof Population and Global Health,
University of Melbourne
Department of Microbiology,
South Eastern Area Laboratory
Services, The Prince of Wales
Hospital
St. Vincent’s Institute of Mental
Health Service (Melbourne), St.
Vincent’s Hospital
School of Psychiatry and Clinical
Neurosciences, Royal Perth
Hospital at the Medical Research
Foundation Building, Universityof Western Australia
Faculty of Health Sciences,
Curtin University

AUS-60

AUS-61

AUS-72

AUS-75

AUS-77

AUS-78

AUS-79

AUS-80

AUS-85

AUS-86

Clinical Policy and Research
Division, Drug and Alcohol
Services South Australia
Population Health Strategic
Research Centre, Faculty of
Health, Deakin University
Monash University Accident
Research Centre
Discipline of Chinese Medicine,
School of Health Sciences,
RMIT University

Title of the Centre

Name of participant/s

WHO Collaborating Centre
for Diagnostics andLaboratory Support for
HIV/AIDS and Other Bloodborne Infections
WHO Collaborating Centre
for the Prevention of
Blindness
WHO Collaborating Centre
for Arbovirus Reference andResearch
WHO Collaborating for
Women’s Health

Dr Susan BestMr Wayne Dimech

WHO Collaborating Centre
for Sexually Transmitted
DiseasesProfessor Monica Lahra
Dr Charles George

WHO Collaborating Centre
for Research and Training in
Mental Health
WHO Collaborating Centre
for Research, Training andConsultative Work on Mental
HealthProfessor Yvonne Bonomo

WHO Collaborating Centre
for Environmental HealthImpact Assessment
WHO Collaborating Centre
for Research in the Treatment
of Drug and Alcohol Problems
WHO Collaborating Centre
for Obesity Prevention

Dr Helen Brown

WHO Collaborating Centre
for Violence, Injuries andDisabilities
WHO Collaborating Centre
for Traditional Medicine

Dr Judith Charlton

15

Dr Andreas Mueller

Professor John Aaskov

Dr Cathy Vaughan

Professor Aleksandar Janca

Professor Robert Ali

Dr Steven Allender

Professor Charlie Changli
Xue
Dr Tony Zhang

AUS-87

Centre for International Child
Health, University of Melbourne

WHO Collaborating Centre
for Research and Training inChild and Neonatal Health
WHO Collaborating Centre
for Capacity Building and
Health Care Worker Training
in HIV/AIDS Care, Treatment
and Support
WHO Collaborating Centre
for Reference and Research on
Influenza

Professor Kim Mulholland

AUS-89

Albion Street Centre

AUS-91

Influenza Reference Laboratory,
Victorian Infectious Diseases
Reference Laboratory

AUS-92Asian Pacific Ubiquitous HealthCare Research Centre, Universityof New South Wales

WHO Collaborating Centre on
eHealthProfessor Siaw-Teng Liaw

AUS-93

Faculty of Nursing, Midwifery &Health, University ofTechnology, Sydney

WHO Collaborating Centre
for Nursing, Midwifery and
Health Development

Ms Michele Rumsey

AUS-98School of Nursing, Midwifery
and Nutrition, James Cook
University Australia

WHO Collaborating Centre
for Nursing and Midwifery
Education and Research
Capacity Building

Professor Caryn West
Professor Stewart Lee

AUS-107

Boden Institute of Obesity,
Nutrition and Exercise and thePrevention Research
Collaboration, Faculty of
Medicine, University of Sydney

WHO Collaborating Centre
for Physical Activity,
Nutrition and Obesity

Ms Elly Howse

AUS-109

Disaster Research Centre,
Flinders University

WHO Collaborating Centre
for Mass Gatherings and HighVisibility/High Consequence
EventsDr Malinda Steenkamp

AUS-110The Food Policy Division, The
George Institute for Global
Health

WHO Collaborating Centre on
Population Salt Reduction

Ms Clare Farrand
Mr Joseph Alvin Santos

AUS-113

Faculty of Health Sciences, The
University of Sydney

WHO Collaborating Centre in
Health Workforce
Development in Rehabilitationand Long Term Care

Professor Gwynnyth
Llewellyn

AUS-114

School of Population Health,
University of Queensland

WHO Collaborating Centre
for Health Information
Systems

Professor Peter Leggat

AUS-117

Victorian Health Promotion
Foundation (VicHealth)

WHO Collaborating Centre
for Excellence in Health
Promotion

Ms Kellie Horton

16

Professor Julian GoldDr Tracey Mills

Professor Ian BarrAUS-118

Centre for Adolescent Health at
the Royal Children’s Hospital,
University of Melbourne

WHO Collaborating Centre
for Adolescent HealthProfessor Susan Sawyer

AUS-121

Research and Molecular
Development, Epidemiology andVirology, Victorian Infectious
Diseases Reference Laboratory (WHO Collaborating Centre
for Viral Hepatitis

Dr Benjamin Cowie
Ms Laura Thomas

CHN-10Shanghai Institute ofCardiovascular Diseases

WHO Collaborating Centre
for Research and Training in
Cardiovascular Diseases

Dr Zhou Jun
Dr Jin Xuejuan

CHN-24China National Center for Food
Safety Risk Assessment

WHO Collaborating Centre
for Food Contamination
Monitoring

Professor Wu Yongning
Dr Zhou Shuang

CHN-26

Research Institute of
Stomatology, Peking University

WHO Collaborating Centre
for the Research and Training
in Preventive Dentistry

Professor Xu Tao
Professor Zheng Shuguo

CHN-27National Institute ofOccupational Health and Poison
Control, Chinese Center for
Disease Control and Prevention
China

WHO Collaborating Centre
for Occupational Health

Dr Sun Xin

CHN-29Shanghai Institute of Planned
Parenthood Research

WHO Collaborating Centre
for Research in Human
Reproduction

Ms Li Yi
Ms Du Shi

CHN-30

Academy of Integrated
Traditional Chinese and Modern
Medicine, Shanghai Medical
College, Fudan University

WHO Collaborating Centre
for Traditional Medicine

Professor Dong Jingcheng

CHN-32

Institute of Acupuncture &Moxibustion, China Academy ofChinese Medical Sciences

WHO Collaborating Centre
for Traditional Medicine

Professor Wang Hongcai
Ms Hong Tao

CHN-33

Shanghai University ofTraditional Chinese Medicine

WHO Collaborating Centre
for Traditional Medicine

Dr Zheng Linyun
Dr Dou Danbo

CHN-34

Institute of Chinese Materia
Medica, China Academy ofChinese Medical

WHO Collaborating Centre
for Traditional Medicine

Mrs Yanan Yuan
Ms Li Jin

CHN-35

Institute of Clinical Research &Information, China Academy ofChinese Medical Sciences

WHO Collaborating Centre
for Traditional Medicine

Professor Zhang Fan

17

CHN-47

Nanjing Child Mental HealthResearch Centre

WHO Collaborating Centre
for Research and Training inChild Mental Health

Dr Ke Xiaoyan
Dr Hui Yao

CHN-50Department of Rehabilitation
Medicine, Sun Yat-Sen
University of Medical Sciences

WHO Collaborating Centre
for Rehabilitation

Professor Huang Dong Feng
Professor Wai Leung
Ambrose Lo

CHN-55

Shanghai Blood Centre

WHO Collaborating Centre
for Blood Transfusion
Services

Professor Zhu Yongming

CHN-56

Sichuan Family PlanningResearch Institute, Chengdu
University of Traditional
Chinese Medicine
Hunan Institute of Parasitic
Diseases

WHO Collaborating Centre
for Research in Human
Reproduction

Professor Xiaozhang Liu
Ms Hanbing Wang

WHO Collaborating Centre on
Schistosomiasis Control in
Lake Regions

Dr Peng Xian-ping

CHN-58

CHN-60Department of Rehabilitation
Medicine, Tongji Hospital,
Tongji Medical College

WHO Collaborating Centre
for Training and Research in
Rehabilitation

Professor Huang Xiaolin

CHN-63National Research Institute for
Family Planning

WHO Collaborating Centre
for Research in Human
Reproduction

Ms Liu Qing
Ms Lyu Yanhong

CHN-65

Institute of Population Research,
Peking University

WHO Collaborating Centre
for Research in Reproductive
Health and Population Science

Dr Zhenjie Wang
Mr Guogui Huang
Mrs Xu Wen
Mrs Fu Yanyan

CHN-74

Women’s and Children’s HealthCare, Peking University

WHO Collaborating Centre
for Research and Training in
Women’s and Children’s
HealthMrs Hao Bo
Ms Zhang Xiaosong

CHN-76

Department of Etiologic
Biology, Second Military
Medical University

WHO Collaborating Centre
for Gene Synthesis andExpression

Dr Zhang Yilong

CHN-77

Center for Disease Control andPrevention of Guangdong
Province

WHO Collaborating Centre
for Surveillance, Research
and Training of Emerging
Infectious Diseases

Dr Song Tie
Ms Luo Haiming

CHN-81

Ministry of Health, Health
Human Resources Development
Center

WHO Collaborating Centre
for Human Resources for
HealthMs Yi Lina

CHN-83

The Hong Kong Society for
Rehabilitation

WHO Collaborating Centre
for Rehabilitation

Ms Monique Kuo

18

CHN-89

School of Nursing, Faculty of
Health and Social Sciences

The Hong Kong Polytechnic
University

Professor Alex Molasiotis
Dr Regina Lee

CHN-91

Centre for Food Safety, Foodand Environmental Hygiene
Department,

WHO Collaborating Centre
for Risk Analysis ofChemicals in Food

Dr Samuel Tze-Kiu Yeung
Dr Tsz-sum Lam

CHN-92

STD/AIDS Centre for Treatment
and Care, Beijing Ditan Hospital

WHO Collaborating Centre
for Comprehensive
Management of HIV
Treatment and Care of HIV
Treatment and Care

Professor Zhang Yong Li
Professor Zhang Fujie

CHN-94

Beijing Tongren Hospital
affiliated with Capital Medical
University, Beijing Institute of
Otorhinolaryngology

WHO Collaborating Centre
for Prevention of Deafness

Dr Huang Lihui
Mr Fu Xinxing

CHN-109

School of Nursing, Shandong
University

WHO Collaborating Centre
for Nursing Care for
Vulnerable Groups, including
those impacted by disasters

Professor Zang Yuli

CHN-110Department of Public Mental
Health, Peking University
Institute of Mental Health

WHO Collaborating Centre
for Research and Training in
Mental Health

Dr Wang Huali

CHN-113

Tobacco Control Office,Department of Health, Hong
Kong SAR

WHO Collaborating Centre
for Smoking Cessation andTreatment of Tobacco
Dependence

Dr Ka Wai Sin

CHN-114

Department of Vector Biology
and Control, National Institutefor Communicable Disease
Control and Prevention, ChineseCentre for Disease Control andPrevention
Chinese Medicine Division,
Department of Health, Hong
Kong SAR

WHO Collaborating Centre
for Vector Surveillance andManagement

Professor Liu Qiyong
Dr Liu Xiaobo

WHO Collaborating Centre
for Traditional Medicine

Mr Tung Cheong, TerenceMan

CHN-118

Health Publishing Research andDevelopment Center, People’s
Medical Publishing HouseWHO Collaborating Centre
for Health Information andPublishing

Mr Feng Xin Zhang
Mrs Hua Bai

CHN-119

School of International Tradeand Economics, University ofInternational Business andEconomics

WHO Collaborating Centre
on Tobacco and Economics

Dr Zheng Rong

CHN-11519

CHN-120

School of Public Health, The
University of Hong Kong

WHO Collaborating Centre
for Infectious Disease
Epidemiology and Control

Professor Wing Hong Seto
Mr Raymond Leung

CHN-121

Xinjiang Key Laboratory of
Echinococcosis, Clinical
Medical Research Institute, The
First Affiliated Hospital of
Xinjiang Medical University

WHO Collaborating Centre
for Prevention and CareManagement of
Echinococcosis

Professor Cui Yan
Professor Wen Hao

CHN-122

Health Quarantine andInspection Department, The
General Administration of
Quality Supervision Inspection
and Quarantine of the People’s
Republic of China

WHO Collaborating Centre
for International HealthRegulations: Points of Entry

Mr Fang Zhiqiang
Ms Huang Li

CHN-123

Jiading Primary Health Care
CentreWHO Collaborating Centre
for Primary Health Care

Ms Xu Haiyan

CHN-126

Institute of Health Quarantine,
Chinese Academy of Inspection
and Quarantine

WHO Collaborating Centre
for International Travel
HealthProfessor Wang Jing

CHN-129

School of Nursing, Peking
Union Medical College

WHO Collaborating Centre
for Nursing Policy-Making
and Leadership

Professor Liu Huaping
Dr Zhao Hong

CHN-130

Institute of Parasitic Diseases,
Chinese Center for Diseases
Control and Prevention

WHO Collaborating Centre
for Tropical Diseases

Mrs Wang Xiaoqi
Dr Guan Yayi

CHN-133

Tobacco Medicine and Tobacco
Cessation Centre, Institute of
Respiratory Medicine

WHO Collaborating Centre
for Tobacco Cessation andRespiratory Diseases
Prevention

Dr Xiao Dan

CHN-136

Jiangsu Institute of Parasitic
Diseases

WHO Collaborating Centre
for Research Training on
Malaria Elimination

Dr Zhu Guoding
Professor Gaoqi Qi

JPN-28Department of Quality
Assurance and RadiologicalProtection, National Institute of
Infectious Diseases

WHO Collaborating Centre
for Standardization and
Evaluation of Biologicals

Dr Atsushi KatoDr Keigo Shibayama
Dr Atsuko Tsutsui

JPN-32

Radiation Effects Research
Foundation

WHO Collaborating Centre
for Research on Radiation
Effects on Humans

Dr Hiroaki Katayama

20

JPN-34

Department of Opthalmology,
School of Medicine, Juntendo
University

WHO Collaborating Centre
for Prevention of Blindness

Dr Koichi Ono

JPN-38

Research Institute ofTuberculosis

WHO Collaborating Centre
for Reference, Research andTraining on Tuberculosis

Dr Norio Yamada

JPN-45

Department of International
Medical Cooperation, National
Centre for Global Health andMedicine

WHO Collaborating Centre
for Health Systems Research

Dr Masato Kasuga
Mr Mitsuaki Kamata
Dr Shinichiro Noda

JPN-46

Oriental Medicine ResearchCenter, Kitasato University

WHO Collaborating Centre
for Traditional Medicine

Dr Hiroshi Odaguchi

JPN-49National Institute for Minamata
DiseaseWHO Collaborating Centre
for Studies on the Health
Effects of Mercury
Compounds

Dr Mineshi Sakamoto

JPN-50Department on International
Health and Collaboration,
National Institute of Public
Health

WHO Collaborating Centre
for Integrated People-Centred
Service Delivery

Dr Tomofumi Sone

JPN-51

Department of Environmental
Health, Water Supply andManagement Section , National
Institute of Public Health

WHO Collaborating Centre
for Community Water Supply
and Sanitation

Dr Dai Shimazaki

JPN-53

Institute of Industrial Ecological
Sciences, University ofOccupational & Environmental
Health

WHO Collaborating Centre
for Occupational HealthProfessor Yasuo Morimoto
Professor Hiroshi Yamato

JPN-54

Department of Japanese Oriental
Medicine, Graduate School of
Medicine and Pharmaceutical
Sciences, University of Toyama

WHO Collaborating Centre
for Traditional Medicine

Professor Yutaka Shimada
Dr Makoto Fujimoto

JPN-56

Diabetes Center, Kyoto Medical
Center, National Hospital
Organization

WHO Collaborating Centre
for Diabetes Treatment and
Education

Dr Shigeo Kono

JPN-57

Kurihama Medical andAddiction Center, National
Hospital Organization

WHO Collaborating Centre
for Research and Training on
Alcohol-Related Problems

Dr Susumu Higuchi
Dr Yosuke Yumoto21

JPN-58

People-Centered Care Research
Department, Research Center,
St. Luke’s International
University People-Centered Care
Research Department, ResearchCenter

WHO Collaborating Centre
for Nursing Development inPrimary Health CareDr Tomoko Kamei
Dr Yoko Shimpuku

JPN-61

Osaka Medical Centre &Research Institute for Maternal& Child Health

WHO Collaborating Centre
for Maternal and Child Health

Dr Takuyo Sato
Ms Satomi Iwamoto

JPN-64

Influenza Virus Research Center,
National Institute of Infectious
Diseases

WHO Collaborating Centre
for Reference and Researchon Influenza

Dr Takato Odagiri
Dr Shinji Watanabe

JPN-67

Department of Virology,
Institute for Tropical Medicine,
Nagasaki University

WHO Collaborating Centre
for Reference and Researchon Tropical and Emerging
Virus Diseases

Professor Kouichi Morita
Dr Meng Ling Moi

JPN-68Department of International
Health and Radiation,
Department of Molecular
Biology, Atomic Bomb Disease
Institute, Nagasaki University
School of Medicine

WHO Collaborating Centre
for Research on RadiationInduced Thyroid Diseases andSurgical Treatment ofRadiation Injuries

Professor Noboru Takamura
Dr Rimi Tsuchiya

JPN-70National Rehabilitation Centre
for Persons with Disabilities

WHO Collaborating Centre
for Disability Prevention andRehabilitation

Dr Yoshiko Tobimatsu

JPN-73

International Health Graduate
School, Tokyo Medical &Dental University

WHO Collaborating Centre
for Healthy Cities and Urban
Policy Research

Professor Keiko Nakamura
Dr Kaoruko Seino

JPN-75

Department of Oral Health
Science, Division of Preventive
Dentistry, Niigata University
Graduate School of Medical and
Dental Sciences

WHO Collaborating Centre
for Translation of Oral Health
Science

Professor Hideo Miyazaki

JPN-76

International Centre for
Research Promotion andInformatics, National Institute ofOccupational Safety and Health

WHO Collaborating Centre
for Occupational Health

Dr Toru Yoshikawa
Dr Tomohide Kubo

JPN-77

University of Hyogo, ResearchInstitute of Nursing Care for
People and Community

WHO Collaborating Centre
for Nursing in Disasters and
Health Emergency
Management

Dr Sonoe Mashino
Professor Aiko Yamamoto

22

JPN-78

Center for China and Asia
Studies, Nihon University

WHO Collaborating Centre
for Research and Training inPopulation, Reproductive
Health and Development

Dr Yasuo Sone
Prof Rikiya Mataukura

JPN-79Research Center for Radiation
Emergency Medicine, National
Institute of Radiological
Sciences, National Institutes for
Quantum and Radiological
Science and Technology
Department of Respiratory
Medicine
Dokkyo Medical University
Koshigaya Hospital
Research Centre for Zoonosis
Control, Hokkaido Univesity
Unit for International
Collaboration on Nutrition andPhysical Activity, National
Institute of Health and Nutrition
Centre for Research andTraining on Interprofessional
Education

WHO Collaborating Centre
for Radiation Emergency
Medicine

Dr Makoto Akashi
Ms Hiroko Ino

WHO Collaborating Centre
for the Prevention andControl of Chronic
Respiratory Diseases
WHO Collaborating Centre
for Zoonoses Control
WHO Collaborating Centre
for Nutrition and Physical
Activity

Mr Clyde Ito

WHO Collaborating Centre
for Research and Training on
Interprofessional Education

Professor Hideomi
Watanabe
Professor Hiromitsu
Shinozaki
Dr Yohei Inaba

JPN-83

JPN-87
JPN-88

JPN-89

JPN-90

JPN-91

JPN-92

JPN-93

JPN-94

Department of Environmental
Health, National Institute of
Public HealthCentre for Environmental and
Health Sciences, Hokkaido
University
Japan Support Center for Suicide
Countermeasures, National
Institute of Mental Health,National Center of Neurology
and Psychiatry
Department of Virology II,
National Institute of Infectious
Diseases
Disease Control and Prevention
Center, National Center for
Global Health and Medicine

MAA-12Tropical Infectious Diseases
Research and Education Centre,
University of Malaya

MAA-14

Institute for Health Systems
Research, Ministry of Health

MAA-15National Pharmaceutical Control
Bureau (NPCB), Ministry of
Health

WHO Collaborating Centre
on Tobacco Testing andResearch
WHO Collaborating Centre
for Environmental Health andPrevention of Chemical
Hazards
WHO Collaborating Centre
for Research and Training in
Suicide Prevention

WHO Collaborating Centre
for Virus Reference andResearch (Enteroviruses)
WHO Collaborating Centre
for Prevention, Preparedness
and Response to Emerging
Infectious Diseases
WHO Collaborating Centre
for Arbovirus Reference &Research (Dengue/Severe
Dengue)WHO Collaborating Centre
for Health Systems Research
and Quality Improvement
WHO Collaborating Centre
for Regulatory Control of
Pharmaceuticals

23

Professor Hiroshi Kida
Dr Norikazu Isoda
Dr Nobuo Nishi

Professor Reiko Kishi
Dr Atsuko Araki

Professor Yutaka Motohashi

Dr Kazushi Yamauchi

Dr Norio Ohmagari

Professor Sazaly Abubakar

Dr Siti Haniza Mahmud
Ms Lee Lan Low
Ms Nurulfajar Mohd JamidMAA-16

National Poison Centre, Science
University of Malaysia(Universiti Sains Malaysia)

WHO Collaborating Centre
for Drug Information

NEZ-13

School of Dentistry, Universityof Otago

NEZ-15

Pacific Paramedical Training
CentrePHL-13

College of Nursing, Universityof the Philippines Manila

PHL-19Department of Parasitology,
Research Institute for Tropical
Medicine
Catholic Industrial Medical
Centre (CIMC), The Catholic
University of Korea

WHO Collaborating Centre
for Dental Epidemiology andPublic Health
WHO Collaborating Centre
for External Quality
Assessment in Health
Laboratory Services
WHO Collaborating Centre
for Leadership in Nursing
Development
WHO Collaborating Centre
for Malaria Diagnosis

KOR-9

KOR-17
KOR-18

KOR-19KOR-24East-West Medical ResearchInstitute, Kyung Hee University
Natural Products ResearchInstitute, Seoul National
University
Department of Preventive
Medicine, Yonsei University
Korean Institute of Tuberculosis,
The Korean National
Tuberculosis Association

KOR-84

National Cancer Center

KOR-86

Occupational Health
Department, Korea Occupational
Safety and Health Agency
Korea Institute of Oriental
Medicine
National Institute of Food andDrug Safety Evaluation(NIFDSE), Ministry of Food andDrug Safety (MFDS)

KOR-89
KOR-90Professor Rahmat Awang
Dr Maizurah Omar
Dr Balamurugan
Tangiisuran
Professor William MurrayThomsonMr Philip John Wakem
Mr Navin Karan

Professor Lourdes Marie
TejeroMrs Jennifer Luchavez
Mr Sherwin Galit

WHO Collaborating Centre
for Occupational Health

Dr Jung-Wan Koo
Professor Myong Jun-Pyo

WHO Collaborating Centre
for Traditional Medicine
WHO Collaborating Centre
for Traditional Medicine

Professor Sanghoon Lee
Dr Seung Min Lee
Professor Youngbae Suh

WHO Collaborating Centre
for Health Systems Research
WHO Collaborating Center
for Research, Training andReference Laboratory on
Tuberculosis
WHO Collaborating Centre
for Cancer Registration,
Prevention and Early
Detection
WHO Collaborating Centre
for Occupational HealthProfessor Sohee Park
Ms Woorim Kim
Dr Kyung Hyun Oh

WHO Collaborating Centre
for Traditional Medicine
WHO Collaborating Centre
for Standardization and
Evaluation of Biologicals

24

Dr Dukhyoung Lee
Ms Joelle Joung

Dr Jang Jin Ryoo
Dr Eun A Kim
Ms Lee Yu-Jeong
Dr Sun Mi Choi
Mrs Jinseok Moon
Dr Sangjin Park

KOR-96

Department of Medical Law andEthics, The Asian Institute of
Bioethics and Health Law,
Yonsei University
Environmental Health Research
Department, National Institute ofEnvironmental Research
School of Public Health, Seoul
National University

WHO Collaborating Centre
for Health Law and Bioethics

Professor So Yoon Kim
Ms Sungkyoung Choi

WHO Collaborating Centre
for Vulnerable Population andEnvironment Health
WHO Collaborating Centre
for Health System and
Financing

Dr Kyunghee Choi
Dr Daeseon Kim
Ms Dohyun Kim
Professor Sun-Young Kim

KOR-99College of Medicine Library,
Seoul National University

WHO Collaborating Centre
for Health Information andLibrary Services

Professor Myoung-don Oh
Ms Eun Sun Park

KOR-101

Research Institute for Healthy
Cities and Health Impact
Assessment, Soonchunyang
University

WHO Collaborating Centre
for Healthy Cities and Healthin All Policies

Dr Yoon Hyung Park
Dr Won Gi Jhang
Ms Jong Yun Choi

KOR-102

JW Lee Center for Global
Medicine, College of Medicine,
Seoul National University

WHO Collaborating Centre
for Educational Development

Professor Jwaseop Shin

KOR-104

Research Institute for
Hospice/Palliative Care, College
of Nursing

WHO Collaborating Centre
for Training in Hospice &Palliative Care

Professor Hye A Yeom
Professor Jinsun Yong

SIN-11

Occupational Safety and Health
Division, Ministry of Manpower

WHO Collaborating Centre
for Occupational Health

Dr Siok Lin Gan

SIN-17

Food Laboratory, Health
Sciences Authority

WHO Collaborating Centre
for Food Contamination
Monitoring

Ms Yat Yun Wei

SIN-18Saw Swee Hock School of
Public Health, National
University of Singapore

WHO Collaborating Centre
for Occupational Health

Dr Norbert Wagner

SIN-21

Health Promotion Board (HPB)

WHO Collaborating Centre
for Health Promotion and
Disease Prevention

Dr Ling Chew
Ms Vasuki Ultravathy

SIN-25

Pharmaceutical Division,
Applied Sciences Group, Health
Sciences Authority

WHO Collaborating Centre
for Medicines Quality
Assurance

Ms Agnes Lee Cheng Chin

SIN-26

Environmental Health Institute,
National Environment Agency

WHO Collaborating Centre
for Reference and Research of
Arbovirus and their
Associated Vectors

Dr Christina Liew

KOR-97

KOR-9825

SIN-28

Centre for Biomedical Ethics,
Yong Loo Lin School of
Medicine, National University ofSingapore

WHO Collaborating Centre
for Bioethics

Dr Calvin HL Ho

VTN-3

National Institute ofOccupational and Environmental
Health

WHO Collaborating Centre
for Occupational Health

Dr Nguyen Bich Diep

VTN-4

National Hospital of Traditional
Medicine

WHO Collaborating Centre
for Traditional Medicine

Dr Le Manh Cuong

AUS-129

McCabe Center for Law andCancer, Cancer Council Victoria

WHO Collaborating Centre
for Law andNoncommunicable Diseases

Ms Evita Mariz Ricafort

JPN-95

Department of Internal
Medicine/Hepatology and
Gastroenterology, Kanazawa
University Hospital, Kanazawa
University

WHO Collaborating Centre
for Chronic Hepatitis andLiver Cancer

Dr Tatsuya Yamashita

OBSERVERS

26

SECRETARIATDr Shin Young-soo

Regional Director

Dr Takeshi Kasai

Director, Programme Management

Mr Jeffery Kobza

Director, Administration and Finance

Dr Mark Jacobs

Director, Communicable Diseases

Dr Vivian Lin

Director, Health Systems

Dr Susan Mercado

Director, Noncommunicable Diseases and Health through Life-Course

Dr Li Ailan

Director, Health Security and Emergencies

Dr Kidong Park

Coordinator, Country Support Unit

Dr Rasul Baghirov

Coordinator, Integrated Service Delivery

Dr Rabindra Romauld Abeyasinghe

Coordinator, Malaria, Other Vectorborne and Parasitic Diseases

Dr Ying-Ru Jacqueline Lo

Coordinator, HIV, Hepatitis and Sexually Transmitted Infection

Dr Noboyuki Nishikiori

Coordinator, Stop TB and Leprosy Elimination

Dr Sergey Diorditsa

Coordinator, Expanded Programme on Immunization

Ms Anjana Bhushan

Coordinator, Equity and Social Determinants

Dr Jun Gao

Coordinator, Health Intelligence and Innovation

Dr David Newby

Coordinator, Essential Medicines and Health Technologies

Dr Ke Xu

Coordinator, Health Policy and Financing

Dr Mohd Nasir Hassan

Coordinator, Health and the Environment

Dr Hai-Rim Shin

Coordinator, Noncommunicable Diseases and Health Promotion

Dr Howard Sobel

Coordinator, Reproductive, Maternal, Newborn, Child and Adolescent
HealthDr Babatunde Olowokure

Coordinator, Emerging Disease Surveillance and Response

Ms Britta Monika Baer

Technical Officer (Gender, Equity, Human Rights and Ageing)

Mr Luke Anthony ElichTechnical Officer (Governance and Legislation)

Dr Ki-Hyun Hahm

Technical Officer (Legislation and Regulation

27

Dr Indrajit Hazarika

Technical Officer (Health Workforce Policy)

Dr Yu Lee Park

Technical Officer (Traditional Medicine)

Dr Sarah PaulinTechnical Officer (AMR)

Dr Darryl Wade Barrett

Technical Lead for Disabilities and Rehabilitation

Dr Katia de Pinho Campos

Technical Officer (Health Promotion)

Dr Katrin Engelhardt

Technical Lead for Nutrition

Mr Khondkar Rifat Hossain

Technical Officer (Water, Sanitation and Hygiene)

Dr Tara Kessaram

Medical Officer (NCD)

Mr Jonathon Passmore

Technical Officer,Violence and Injuries

Mr Peter Hoejskov

Technical Officer (Food Safety)

Dr Frank Konings

Technical Officer (Laboratory)

Dr Angela Pratt

Executive Officer, Office of the Regional Director

Ms Marie Sarah Villemin-Partow

Technical Lead for Information Products and Services

Mr Eloi Yao

Public Information Officer

Dr Rodel Nodora

Technical Officer (Collaboration, Partnership and Reform)

Ms Nicole Sarkis

Programme Management Officer

Ms Laura Davison

Programme Management Officer

Ms Mary Ann Gamilla

Administrative Officer

Ms Elaine O'Leary

Consultant, Division of Health Systems

Dr Bai-Fang Sobel

Consultant, Division of Noncommunicable Diseases and Health throughthe Life-Course

Mr Matias Tuler

Programme Manager, Strategy, Policy and Information, WHO
Headquarters

28

ANNEX 3
OUTCOMES OF PARALLEL SESSIONS
3.1

Technical Parallel Sessions

A. Communicable diseases
A1. HIV, hepatitis and sexually transmitted infections
Facilitator: Dr Ying-Ru Lo
Key message:
WHO’s work in collaboration with WHO collaborating centres (CCs) will focus on supporting
countries to implement three interlinked global health sector strategies for HIV, hepatitis andsexually transmitted infections (STIs) covering the period 2016–2021, which respectively call foran end to the AIDS epidemic, viral hepatitis, and the STI epidemic as public health threats by
2030.
Recommendations:
WHO CCs and WHO agreed to:
•
•
•
•

•
•

develop/refine WHO CC activities in the context of the new global strategies and SDGs as well as
limited resources for HIV, hepatitis and STI programmes;
ensure support for the implementation of the Regional Action Plan for Viral Hepatitis in theWestern Pacific;
disseminate HIV and hepatitis guidance where most needed;
support initiation and augmentation of hepatitis and HIV surveillance and data management in
Member States, including expanding training on infection prevention and control for nurses andother health care workers and outbreak investigation tools for blood-borne viruses such as hepatitis
C and HIV;strengthen laboratory services, focusing on improving the quality of HIV, hepatitis and STI
testing, including the use of point-of-care diagnostics; andstrengthen HIV and STI prevention focusing on men who have sex with men, the prevention andsurveillance of gonorrhoea antimicrobial drug resistance, and strengthening sustainable service
delivery models for HIV and STI care.
Participating WHO collaborating centres:

•
•
•
•
•

AUS-45: St Vincent’s Institute of Medical Research, National Serology Reference Laboratory;
WHO Collaborating Centre for Diagnostics and Laboratory Support for HIV/AIDS and Other
Blood-borne Infections
AUS-72: The Prince of Wales Hospital, Department of Microbiology, South Eastern Area
Laboratory Services; WHO Collaborating Centre for Sexually Transmitted Diseases
AUS-89: Albion Street Centre; WHO Collaborating Centre for Capacity Building and Health Care
Worker Training in HIV/AIDS Care, Treatment and Support
AUS-121: Victorian Infectious Diseases Reference Laboratory, Research and Molecular
Development, Epidemiology, and Virology; WHO Collaborating Centre for Viral Hepatitis
CHN-75: National Center for Sexually Transmitted Diseases Control, Institute of Dermatology,
Chinese Academy of Medical Sciences and Peking Union Medical College; WHO Collaborating
Centre for the Prevention and Control of Sexually Transmitted Infections29

•CHN-92: STD/AIDS Centre for Treatment and Care Beijing Ditan Hospital; WHO Collaborating
Centre for Comprehensive Management of HIV Treatment and Care
A2. Tuberculosis (TB)
Facilitator: Dr Nobuyuki Nishikiori
Key message:
WHO CCs are fully committed to collaborative work with WHO in line with the WHO End TB
Strategy and the SDGs.
Recommendations:
WHO CCs and WHO agreed to:••develop a regional guidance document on TB control among older people; andmaintain the level of coordination and collaboration in supporting countries in implementing the
End TB Strategy, including in the areas of access to latest diagnostic technologies, implementing
patient cost studies and other operational research to generate evidence on social interventions in
TB care and prevention.
Participating WHO collaborating centres :•••CHN-57: Beijing Tuberculosis and Thoracic Tumor Research Institute, National Center for TB
Control and Clinical Medicine, Chinese Center for Disease Control and Prevention; WHO
Collaborating Centre for Research and Training on Tuberculosis
JPN-38: Research Institute of Tuberculosis; WHO Collaborating Centre for Reference, Research
and Training on Tuberculosis
KOR-24: Korean Institute of Tuberculosis, The Korean National Tuberculosis Association; WHO
Collaborating Centre for Research, Training and Reference Laboratory on Tuberculosis
A3. Malaria, other vector borne and neglected tropical diseases
Facilitator: Dr Rabindra Abeyasinghe
Key message:
With the endorsement of the Global Strategies and Regional Action Plans, key work areas
pertaining to malaria, dengue and other neglected tropical diseases must be aligned with the SDGs.
Recommendations:
WHO CCs and WHO agreed to:•••work jointly to amplify the effectiveness of WHO work in countries;
explore opportunities to further expand the support provided to Member States to improve theirhealth status through addressing targets related to the Malaria, Other Vectorborne and Parasitic(MVP) Diseases Programme and the Expanded Programme on Immunization (EPI), especially theelimination and control of these diseases;
maintain, sustain and create innovative partnerships, including through exploring opportunities tostrengthen cooperation to facilitate enhanced country support; and30

•

ensure that activities and work related to EPI laboratory surveillance of poliovirus and otherenteroviruses are aligned with the SDGs.
Participating WHO collaborating centres:

•
•
•
•
•
•
•
•
•
•
•
•

AUS-60: Queensland University of Technology; WHO Collaborating Centre for Arbovirus
Reference and Research
AUS-68: James Cook University Australia School of Public Health, Tropical Medicine andRehabilitation Sciences; WHO Collaborating Centre for the Control of Lymphatic Filariasis, Soiltransmitted Helminths and other Neglected Tropical Diseases
CHN-58: Hunan Institute of Parasitic Diseases; WHO Collaborating Centre on Schistosomiasis
Control in Lake Regions
CHN-76: Second Military Medical University, Department of Etiologic Biology; WHO
Collaborating Centre for Gene Synthesis and Expression
CHN-114: Department of Vector Biology and Control, National Institute for Communicable
Disease Control and Prevention; WHO Collaborating Centre for Vector Surveillance andManagement
CHN-121: Xinjiang Key Laboratory of Echinococcosis, Clinical Medical Research Institute,
The First Affiliated Hospital of Xinjiang Medical University; WHO Collaborating Centre forPrevention and Care Management of Echinococcosis
CHN-130: Chinese Center for Diseases Control and Prevention, Institute of Parasitic Diseases;
WHO Collaborating Centre for Tropical Diseases
CHN-136: Jiangsu Institute of Parasitic Diseases; WHO Collaborating Centre for Research andTraining on Malaria Elimination
JPN-93: Department of Virology II, National Institute of Infectious Diseases; WHO Collaborating
Centre for Virus Reference and Research (Enteroviruses)
MAA-13: Division of Medical Entomology, Institute for Medical Research; WHO Collaborating
Centre for Ecology, Taxonomy and Control of Vectors of Malaria, Filariasis and Dengue
PHL-19: Department of Parasitology, Research Institute for Tropical Medicine; WHO
Collaborating Centre for Malaria Diagnosis
SIN-26: Environmental Health Institute, National Environment Agency; WHO Collaborating
Centre for Reference and Research of Arbovirus and their Associated Vectors
B. Health systems
B1. Health research ethics and law
Facilitators: Dr Ki Hyun Hahm; Mr Luke ElichKey messages:•••

Integral to advancing the SDGs, health ethics and law offer constructive perspectives on thechallenges faced by countries, and make important contributions to improving health andsustainable development in the Region.
Health law can play an important role in protecting health rights, facilitating access to healthinterventions, promoting healthy environments and encouraging healthy behaviours. Health law
can also enable countries to overcome programmatic silos, foster intersectoral engagement andsupport health system sustainability.
Health ethics, which encompasses medical ethics, bioethics and “boundaries of life” issues, publichealth ethics, and research ethics, has broad and fundamental implications for health professionals,
policy-makers and researchers, as well as patients, families, and communities.

31

Recommendations:
WHO CCs and WHO agreed to:•••strengthen networks for health law in the Region, including WHO CCs and other well-positioned
institutions and individuals, to improve countries’ access to expertise and resources on theeffective use of law to improve health;identify the important issues in the Region that health ethics can help address, and the best
institutional mechanisms and approaches to implementation; andfoster collaboration across health ethics and law and other areas as appropriate, recognizing theneed to work together to maximize effectiveness.
Participating WHO collaborating centres:••

KOR-96: Department of Medical Law and Ethics, The Asian Institute of Bioethics and Health
Law, Yonsei University; WHO Collaborating Centre for Health Law and Bioethics
SIN-28: Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University ofSingapore; WHO Collaborating Centre for Bioethics
B2. Essential medicines, health technology and biologicals
Facilitator: Dr David Newby
Key messages:• WHO CCs provide important support to Member States on regulatory system strengthening;
however, there are gaps in the support for work on AMR and access to essential medicines.
• Greater engagement between WHO CCs and WHO will improve the effectiveness of activities incountries.
Recommendations:
WHO CCs and WHO agreed to:••••increase WHO CC engagement in priority area activities, e.g. including the participation of WHO
CCs as observers at regional meetings and in country missions, etc.;
consider organizing more regular video/teleconferences;
explore how WHO CCs’ current work plans can be enhanced to increase their impact in countries;
andensure that all reporting and proposals for redesignation address the need for broader in-country
work that reflects country SDG priorities.
Participating WHO collaborating centres:

•
•
•
•

CHN-117: National Institutes for Food and Drug Control; WHO Collaborating Centre forStandardization and Evaluation of Biologicals
JPN-28: Department of Quality Assurance and Radiological Protection, National Institute of
Infectious Diseases; WHO Collaborating Centre for Standardization and Evaluation of Biologicals
KOR-90: National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug
Safety; WHO Collaborating Centre for Standardization and Evaluation of Biologicals
MAA-15: National Pharmaceutical Control Bureau, Ministry of Health; WHO Collaborating
Centre for Regulatory Control of Pharmaceuticals

32

•
•
•

MAA-16: National Poison Centre, Universiti Sains Malaysia; WHO Collaborating Centre for Drug
Information
NEZ-15: Pacific Paramedical Training Centre; WHO Collaborating Centre for External Quality
Assessment in Health Laboratory Services
SIN-25: Health Sciences Authority; WHO Collaborating Centre for Medicines Quality Assurance
B3. Health information and e-healthFacilitator: Dr Jun Gao
Key messages:• Health information and the improved application of information and communication technology onhealth (eHealth) are important to the achievement of the SDGs.
• Health information systems and eHealth are strengthened through better application of international
health information standards.
Recommendations:
WHO CCs and WHO agreed to:••••improve communications between technical focal persons, including through regularteleconferences;improve trust and understanding through better communication and developing common agreed
actions and expected outputs to support countries;
work with regional networks such as AeHIN, PHIN, etc., and other partners to improve healthinformation systems and eHealth across the Region; andincrease collaboration on eHealth evaluation, assessment and capacity building in countries.
Participating WHO collaborating centres:

•
•
•
•

AUS-114: University of Queensland, School of Population Health; WHO Collaborating Centre for
Health Information Systems
AUS-92: University of New South Wales, International Laboratory for Air Quality and Health;
WHO Collaborating Centre on eHealth
CHN-112: National Health and Family Planning Commission of the People’s Republic of China,
Center for Health Statistics and Information; WHO Collaborating Centre for Health Information
and Informatics
JPN-85: International Classification and Information Management Office (Japan ICD Office),
Policy Planning Division, Statistical and Information Department, Minister’s Secretariat, Ministryof Health, Labour and Welfare; WHO Collaborating Centre for the Family of International
Classifications33

B4. Health workforce
Facilitator: Dr Indrajit Hazarika
Key messages:•••

The health workforce is critical for achieving UHC and other health-related SDGs.
Future work should adopt a health systems approach, aligning the health workforce with service
needs and effectively using health governance and financing policy levers.
Strengthening the capacity of the public health workforce can improve the resilience of
health systems.
Recommendations:
WHO CCs and WHO agreed to:

•
•
•
•
•
•

continue regular communication within the WHO CC network, using platforms such as
GoToMeeting, to review progress and share experiences and achievements;
plan joint activities among WHO CCs working on different thematic areas to adopt a more
consolidated approach to addressing health needs;
transition to a multidisciplinary approach to supporting health workforce needs and implementing
activities in Member States;
establish priority areas of focus among WHO CCs and WHO to enable capacity building, training
and research outcomes;
provide responsive support to Member States on key areas, such as clinical governance/riskmanagement, health professions education reforms, leadership training, and developing a skilledworkforce to address current and emerging health threats; andreview the terms of reference of WHO CCs at the time of re-designation to strengthen theiralignment with the identified priorities of Member States.
Participating WHO collaborating centres:

•
•
•
•
•
•
•
•
•
•

AUS-93: University of Technology, Sydney, Faculty of Nursing, Midwifery & Health; WHO
Collaborating Centre for Nursing, Midwifery and Health Development
AUS-98: James Cook University Australia, School of Nursing, Midwifery and Nutrition; WHO
Collaborating Centre for Nursing and Midwifery Education and Research Capacity Building
CHN-81: Health Human Resources Development Center, Ministry of Health; WHO Collaborating
Centre for Human Resources for Health
CHN-109: Shandong University; WHO Collaborating Centre for Nursing Care for Vulnerable
Groups, including those impacted by disasters
CHN-129: School of Nursing, Peking Union Medical College; WHO Collaborating Centre for
Nursing Policy-Making and Leadership
JPN-58: People-Centered Care Research Department, Research Center, St. Luke’s International
University; WHO Collaborating Centre for Nursing Development in Primary Health Care
JPN-77: University of Hyogo, Research Institute of Nursing Care for People and Community;
WHO Collaborating Centre for Nursing in Disasters and Health Emergency Management
JPN-89: Centre for Research and Training on Interprofessional Education, Gunma University;
WHO Collaborating Centre for Research and Training on Interprofessional Education
KOR-102: JW Lee Center for Global Medicine, College of Medicine Seoul National University;
WHO Collaborating Centre for Educational Development
KOR-16: College of Nursing, Yonsei University; WHO Collaborating Centre for Research andTraining for Nursing Development in Primary Health Care34

•

PHL-13: College of Nursing, University of the Philippines Manila; WHO Collaborating Centre for
Leadership in Nursing Development
B5. Service delivery and financing
Facilitators: Dr Rasul Baghirov; Dr Xu Ke
Key messages:• Work on strengthening health systems should be undertaken in teams, because synergetic action isnecessary to achieve UHC. A separate focus on service delivery, financing or governance alone will
not succeed.
• The regional action framework on UHC provides a platform for WHO CCs to amplify WHO efforts
in supporting Member States to develop and implement WHO country roadmaps. WHO CCs areinvited to use the framework, available online at http://www.uhcwpr.info/.
• Joint activities, similar to the ongoing annual training course on hospital quality management, areeffective and should be continued.
Recommendations:
WHO CCs and WHO agreed to:•••organize teleconference sessions to review progress and discuss technical collaborations asneeded;maintain close communications, updating each other on matters to better inform and shaperespective performance; andexpand the scope and participation in hospital management courses and involve WHO CCs incapacity-building activities at the country level.
Participating WHO collaborating centres:

•
•
•
•
•
•
•
•
•
•

CHN-55: Shanghai Blood Centre; WHO Collaborating Centre for Blood Transfusion Services
CHN-120: School of Public Health, The University of Hong Kong; WHO Collaborating Centre for
Infectious Disease Epidemiology and Control
CHN-123: Jiading Primary Health Care Centre; WHO Collaborating Centre for Primary HealthCare
CHN-127: China National Health Development Research Center; WHO Collaborating Centre for
Health Systems Strengthening
JPN-45: Department of International Medical Cooperation, National Centre for Global Health andMedicine; WHO Collaborating Centre for Health Systems Research
JPN-50: Department of International Health and Collaboration, National Institute of Public Health;
WHO Collaborating Centre for Integrated People-Centred Service Delivery
KOR-19: Department of Preventive Medicine, Yonsei University, College of Medicine; WHO
Collaborating Centre for Health Systems Research
KOR-98: School of Public Health, Seoul National University; WHO Collaborating Centre for
Health System and Financing
KOR-100: Korean Red Cross Blood Service, Korean Red Cross; WHO Collaborating Centre forBlood Transfusion Safety
MAA-14: Institute for Health Systems Research, Ministry of Health; WHO Collaborating Centre
for Health Systems Research and Quality Improvement35

B6. Traditional medicine
Facilitator: Dr Yu Lee Park
Key messages:• Traditional medicine activities need to be reviewed from a broader public health perspective.
• Greater attention needs to be paid to the contribution of traditional medicines to UHC
and the SDGs.
• Activities of the WHO CCs for traditional medicine must be aligned with WHO activities tosupport Member States in achieving UHC and the SDGs.
• More active engagement and efficient communication between WHO and WHO CCs is essential.
Recommendations:•••

WHO CCs and WHO agreed to:strengthen communications to identify and implement collaborative activities to support Member
States, including identifying at least one key activity for each WHO CC;
use existing meetings such as the Joint Symposium to discuss WHO key priority areas such as
adverse event reporting systems, information systems, and regulation of products/practitioners, aswell as to provide inputs to WHO; andwork on WHO CC sharing of more detailed and key research and related achievements, in addition
to annual reports, and to discuss strategies to disseminate and translate the research into action.
Participating WHO collaborating centres:

•
•
•
•
•
•
•
•
•
•
•

AUS-86: RMIT University, Discipline of Chinese Medicine, School of Health Sciences; WHO
Collaborating Centre for Traditional Medicine
CHN-30: Academy of Integrated Traditional Chinese and Modern Medicine, Shanghai Medical
College, Fudan University; WHO Collaborating Centre for Traditional Medicine
CHN-32: Institute of Acupuncture & Moxibustion, China Academy of Chinese Medical Sciences;
WHO Collaborating Centre for Traditional Medicine
CHN-33: Shanghai University of Traditional Chinese Medicine; WHO Collaborating Centre for
Traditional Medicine
CHN-34: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences;
WHO Collaborating Centre for Traditional Medicine
CHN-35: Institute of Clinical Research & Information, China Academy of Chinese Medical
Sciences; WHO Collaborating Centre for Traditional Medicine
CHN-44: Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences; WHO
Collaborating Centre for Traditional Medicine
CHN-115: Chinese Medicine Division, Department of Health, Hong Kong SAR; WHO
Collaborating Centre for Traditional Medicine
JPN-46: Oriental Medicine Research Centre (OMRC), Kitasato University; WHO Collaborating
Centre for Traditional Medicine
JPN-54: Department of Japanese Oriental Medicine, Graduate School of Medicine andPharmaceutical Sciences, University of Toyama; WHO Collaborating Centre for
Traditional Medicine
KOR-17: East-West Medical Research Institute Kyung Hee University; WHO Collaborating
Centre for Traditional Medicine

36

•
•
•

KOR-18: Natural Products Research Institute, Seoul National University; WHO Collaborating
Centre for Traditional Medicine
KOR-89: Korea Institute of Oriental Medicine; WHO Collaborating Centre for
Traditional Medicine
VTN-4: National Hospital of Traditional Medicine; WHO Collaborating Centre for
Traditional Medicine
C. Non-communicable diseases and health through the life-course
C1. Joint parallel session on Non-communicable Diseases, Health Promotion, Healthy Diet
and Oral Health and Tobacco Free Initiative
Facilitators: Dr Hai-Rim Shin, Dr Tara Kessaram, Dr Katrin Engelhardt, Ms Katia de Pinho
CamposKey messages:• Detailed strategies can be explored in designing, implementing and evaluating
programme interventions.
• Health promotion has a significant role to play in the sustainable development agenda.
• WHO CCs have experience in applying systems approaches to address non-communicable diseases
and their risk factors, and promoting the use of existing system tools. Interventions at the level ofsystems and environments are necessary to improve health outcomes of individuals andpopulations.
• It is important for the SDGs, WHO action plans and terms of reference of WHO CCs to be related
to and aligned with one another.
Recommendations:
WHO agreed to:
•
•
•
•
•

strengthen coordination between and among WHO headquarters, the Regional Office and WHO
CCs;build programme- or theme-specific networks of WHO CCs so that thematic meetings can be held
either in person or via video/teleconference;
make progress on an interactive website that has mailing lists and online forums through which
WHO CCs can interact with WHO and with one other;move forward on the idea of designating more WHO CCs in the areas of health policy, law, tradeand economics; anddevelop a monitoring/tracking mechanism for statements/agreements made at this meeting that are
expected to be implemented in the months to come.
WHO CCs and WHO agreed to:••better align their terms of reference and activities (current and future) to contribute more to the
SDG targets; andmaintain open and regular communication with WHO and among one another.

37

Participating WHO collaborating centres:
Non-communicable diseases
•
•
•
•
•

CHN-10: Shanghai Institute of Cardiovascular Diseases; WHO Collaborating Centre for Research
and Training in Cardiovascular Diseases
JPN-56: Diabetes Center, Kyoto Medical Center, National Hospital Organization; WHO
Collaborating Centre for Diabetes Treatment and Education
JPN-83: Department of Respiratory Medicine, Dokkyo Medical University Koshigaya Hospital;
WHO Collaborating Centre for the Prevention and Control of Chronic Respiratory Diseases
KOR-84: National Cancer Center; WHO Collaborating Centre for Cancer Registration,
Prevention and Early Detection
KOR-104: Research Institute for Hospice/Palliative Care, College of Nursing, The Catholic
University of Korea; WHO Collaborating Centre for Training in Hospice & Palliative Care
Health promotion

•
•
•
•

AUS-117: Victorian Health Promotion Foundation; WHO Collaborating Centre for Excellencein Health Promotion
JPN-73: International Health Graduate School, Tokyo Medical & Dental University; WHO
Collaborating Centre for Healthy Cities and Urban Policy Research
KOR-101: Research Institute for Healthy Cities and Health Impact Assessment, Soonchunhyang
University; WHO Collaborating Centre for Healthy Cities and Health in All Policies
SIN-21: Health Promotion Board; WHO Collaborating Centre for Health Promotion
and Disease Prevention
Healthy diet and oral health

•
•
•
•
•
•
•

AUS-80: Deakin University, Population Health Strategic Research Centre, Faculty of Health;
WHO Collaborating Centre for Obesity Prevention
AUS-107: University of Sydney, Boden Institute of Obesity, Nutrition and Exercise and thePrevention Research Collaboration, Faculty of Medicine; WHO Collaborating Centre for Physical
Activity, Nutrition and Obesity
AUS-110: The George Institute for Global Health, The Food Policy Division; WHO Collaborating
Centre on Population Salt Reduction
CHN-26: Research Institute of Stomatology, Peking University; WHO Collaborating Centre for
the Research and Training in Preventive DentistryJPN-75: Department of Oral Health Science, Division of Preventive Dentistry, Niigata University
Graduate School of Medical and Dental Sciences; WHO Collaborating Centre for Translation of
Oral Health Science
JPN-88: Unit for International Collaboration on Nutrition and Physical Activity, National Instituteof Health and Nutrition; WHO Collaborating Centre for Nutrition and Physical Activity
NEZ-13: School of Dentistry, University of Otago; WHO Collaborating Centre for Dental
Epidemiology and Public HealthTobacco -Free Initiative••

CHN-113: Tobacco Control Office, Department of Health, Hong Kong SAR; WHO Collaborating
Centre for Smoking Cessation and Treatment of Tobacco Dependence
CHN-119: School of International Trade and Economics, University of International Business andEconomics; WHO Collaborating Centre on Tobacco and Economics

38

•
•

CHN-133: Tobacco Medicine and Tobacco Cessation Centre, Institute of Respiratory Medicine;
WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention
JPN-90: Department of Environmental Health, National Institute of Public Health; WHO
Collaborating Centre on Tobacco Testing and Research
C2. Mental health and substance abuse
Facilitators: Dr Xiao Sobel, Dr Jason Ligot, Dr Carmela Mijares-Majini
Key message:
Increasing alignment with the SDGs and increasing the effectiveness of activities in countries isessential.
Recommendations:
WHO CCs and WHO agreed to:

•
•
•
•
•
•

increase the alignment of WHO CC activities with the SDGs and with country priorities to amplify
the effectiveness of WHO work in countries;
promote collaboration on cross-cutting and multidisciplinary issues that impact mental health;foster closer technical interaction and innovative partnerships, including through a dedicatedcommunications platform and strengthened knowledge management strategies;
promote distance learning models to support capacity building;
explore multi-centric research studies and projects on priority issues (e.g. youth suicide); andexplore innovative models for research collaboration between WHO CCs using available data.
Other items considered for development:•••

mental health and substance abuse policy database or observatory;
advocacy product highlighting evidence-based mental health promotion interventions;
campaigns, activities and initiatives with key messages for different audiences and across various
forms of media to support World Health Day 2017 on depression.
Participating WHO collaborating centres:

•
•
•
•
•
•
•

AUS-75: St Vincent’s Hospital: WHO Collaborating Centre for Research and Training in
Mental Health
AUS-77: University of Western Australia, School of Psychiatry and Clinical Neurosciences,
Royal Perth Hospital at the Medical Research Foundation Building; WHO Collaborating Centre
for Research, Training and Consultative Work on Mental Health
AUS-79: Drug and Alcohol Services South Australia, Clinical Policy and Research Division;
WHO Collaborating Centre for Research in the Treatment of Drug and Alcohol Problems
CHN-47: Nanjing Child Mental Health Research Centre; WHO Collaborating Centre for
Research and Training in Child Mental Health
CHN-110: Department of Public Mental Health, Peking University Institute of Mental Health;
WHO Collaborating Centre for Research and Training in Mental Health
JPN-57: Kurihama Medical and Addiction Center, National Hospital Organization;
WHO Collaborating Centre for Research and Training on Alcohol-related Problems
JPN-92: Center for Suicide Prevention, National Institute of Mental Health, National Center of
Neurology and Psychiatry; WHO Collaborating Centre for Research and Training in
Suicide Prevention

39

C3. Disability and rehabilitation
Facilitator: Dr Darryl Wade Barrett
Key messages:••

Strengthening engagement and effective communications can yield better results.
Work plan activities must be aligned with country priorities and attainment of the SDGs,
and implemented as agreed.
Recommendations:
WHO CCs and WHO agreed to:•increase alignment with the SDGs, including by:o initiating cross-sectoral opportunities to improve alignment within WHO programmes andunits, and among all regional CCs to support SDG attainment (ongoing);o increasing transparency of WHO and WHO CC activities to improve two-way
communication and opportunities (ongoing);o increasing demonstration of how WHO and WHO CCs can work together acrossboundaries in various countries (ongoing);o mapping WHO and WHO CC activities to the SDGs to explore priority opportunities toinfluence government policies/programmes (July 2017);
o developing closer links between WHO and WHO CCs.

•

amplify the effectiveness of WHO work in countries, including by:o collaborating more closely with national programmes/partners through WHO,
including setting priorities for activities towards SDGs;
o ensuring that in-country work undertaken with WHO and WHO CCs are followed up,
monitored/evaluated and communicated, working towards establishing a clear governancestructure for in-country WHO CC work (December 2017);
o better sharing of information about country-based work, including plans, to support closer
links and collaboration.
• maintain, sustain and create innovative partnerships, including through clearer and closer
relationships between WHO headquarters, the Regional Office and respective WHO CCs,
particularly for WHO CCs in the region that are managed by WHO headquarters.
Participating WHO collaborating centres:

•
•
•
•
•
•
•

AUS-59: Royal Victorian Eye and Ear Hospital, The Centre for Eye Research Australia;
WHO Collaborating Centre for the Prevention of Blindness
AUS-85: Monash University, Accident Research Centre; WHO Collaborating Centre for Violence,
Injuries and Disabilities
AUS-113: The University of Sydney, Faculty of Health Sciences; WHO Collaborating Centre
in Health Workforce Development in Rehabilitation and Long Term Care
CHN-50: Sun Yat-Sen University of Medical Sciences, Department of Rehabilitation Medicine;
WHO Collaborating Centre for Rehabilitation
CHN-60: Tongji Medical College Department of Rehabilitation Medicine, Tongji Hospital;
WHO Collaborating Centre for Training and Research in Rehabilitation
CHN-83: The Hong Kong Society for Rehabilitation; WHO Collaborating Centre for
Rehabilitation
CHN-87: Nanjing Medical University; WHO Collaborating Centre for the Prevention of
Deafness and Hearing Impairment
40

•
•
•

CHN-94: Beijing Institute of Otorhinolaryngology, Beijing Tongren Hospital affiliated with
Capital Medical University; WHO Collaborating Centre for Prevention of Deafness
JPN-34: Department of Ophthalmology, School of Medicine, Juntendo University;
WHO Collaborating Centre for Prevention of Blindness
JPN-70: National Rehabilitation Centre for Persons with Disabilities; WHO Collaborating
Centre for Disability Prevention and Rehabilitation
C4. Reproductive, maternal, neonatal, child and adolescent health (RMNCAH)
Facilitator: Dr Howard Sobel
Key messages:• Information sharing between WHO and WHO CCs must be continued.
• Engagement is needed with WHO CCs and units relevant to RMNCAH, such as mental health andenvironmental health.
• As adolescent health is the newcomer to the SDGs, it needs continued support, but neither WHO
nor the WHO CCs should forget the Millennium Development Goals (MDGs) that have yet to beachieved, such as those concerning reproductive, maternal, newborn and child health.
Recommendations:
WHO CCs and WHO agreed to:•••continue to facilitate sharing of information through newsletters and direct work;
share publications and relevant reports across the network and relevant ones outside RMNCAH;
andcontinue to translate global evidence into local action both in adolescent health and the MDGs on
reproductive, maternal, newborn and child health, which have yet to be achieved.
Participating WHO collaborating centres:

•
•
•
•
•
•
•
•
•
•

AUS-61: University of Melbourne, Centre for Health Equity, School of Population and
Global Health; WHO Collaborating Centre for Women’s Health
AUS-87: University of Melbourne, Centre for International Child Health; WHO Collaborating
Centre for Research and Training in Child and Neonatal Health
AUS-118: Centre for Adolescent Health at the Royal Children’s Hospital, University of
Melbourne; WHO Collaborating Centre for Adolescent Health
CHN-29: Shanghai Institute of Planned Parenthood Research; WHO Collaborating Centre
for Research in Human Reproduction
CHN-56: Chengdu University of Traditional Chinese Medicine; WHO Collaborating Centre
for Research in Human Reproduction
CHN-63: National Research Institute for Family Planning; WHO Collaborating Centre
for Research in Human Reproduction
CHN-65: Institute of Population Research, Peking University; WHO Collaborating Centre
for Research in Reproductive Health and Population Science
CHN-74: Women’s and Children’s Health Centre, Peking University; WHO Collaborating Centre
for Research and Training in Women’s and Children’s Health
CHN-89: School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic
University; WHO Collaborating Centre for Community Health Services
JPN-61: Osaka Medical Centre & Research Institute for Maternal & Child Health;
WHO Collaborating Centre for Maternal and Child Health41

•JPN-78: Center for China and Asian Studies, Nihon University; WHO Collaborating Centre
for Research and Training in Population, Reproductive Health and Development
C5. Environmental healthFacilitator: Dr Rifat Hossain
Key messages:• It needs to be ensured that the SDGs provide great impetus for collaboration and action
between the health and environment sectors.
• A detailed work plan related to SDGs needs to be developed, based on the field of interest.
Recommendations:
WHO CCs and WHO agreed to:
•
•
•
•
•

identify data gaps to support monitoring of indicators related to SDGs 3, 6, 11 and 13,
and explore model-based estimates to support SDG monitoring where data are lacking;consider cost-benefit analyses of various data scenarios;
collate national policies and legislation to identify areas for improvement and focus;
identify ways to collaborate with other UN agencies on the SDGs mentioned above, such as with
the United Nations Environment Programme (UNEP) on environmental indicators, International
Labour Organization (ILO) on occupational health indicators, etc.; andidentify ways of accessing funds from sources like the Global Environment Facility,
the Green Climate Fund, etc.
Participating WHO collaborating centres:

•
•
•
•
•

AUS-78: Curtin University Faculty of Health Sciences; WHO Collaborating Centre forEnvironmental Health Impact Assessment
JPN-49: National Institute for Minamata Disease; WHO Collaborating Centre for Studies on the
Health Effects of Mercury Compounds
JPN-51: Department of Water Supply Engineering, National Institute of Public Health;
WHO Collaborating Centre for Community Water Supply and Sanitation
JPN-91: Centre for Environmental and Health Sciences, Hokkaido University; WHO
Collaborating Centre for Environmental Health and Prevention of Chemical Hazards
KOR-97: Environmental Health Research Department, National Institute of Environmental
Research; WHO Collaborating Centre for Vulnerable Population and Environmental Health42

C6. Occupational healthFacilitator: Dr Mohammed Nasir Hassan
Key message:• Strengthened collaboration is needed to initiate and/or continue activities that build on theachievements of the Regional Framework for Action for Occupational Health 2011–2015
in key countries.
Recommendations:
WHO CCs and WHO agreed to:••support strengthening of countries’ capacities to achieve UHC for all workers and to achieve theSDGs related to occupational health in the following priority focus areas:o safe and healthy health-care facilities, including topics such as: assessment of risks tohealth-care workers/monitoring and evaluation for general workplaces and in the informal
sector; and provision of fatigue assessment tools and human care ergonomic checkpoints inhealth-care facilities;o management of major occupational hazards (chemicals, asbestos, dust, noise, ergonomics,
radiation and stress), including topics such as: dose estimation for radiation workers;
investigation of “ninja” workers in Mongolian coal mines; guidelines on risk assessmentand management of high-risk sectors; guidelines for occupational disease surveillancesystems; study of heat stress in the construction sector; management of asbestos victims;
and asbestos measurement and analysis;o general workplace health, including topics such as: prevention and management ofoccupational lung disease; occupational disease reporting system; chemical and biologicalmonitoring method (Biological Exposure Index); participatory action-oriented
training/tools/Ebola;o informal workers and vulnerable populations such as those in mining and other primary
production sectors, including topics such as: provision of basic occupational health services
for small- and medium-sized enterprises; teaching labour rights to young workers,
especially in the informal sector; anddevelop the following occupational health country/regional profiles: working populations exposedto specific chemicals; coverage of occupational health services; and number of work-relateddiseases from exposure to specific hazards.
Participating WHO collaborating centres:

•
•
•
•

•
•

CHN-27: National Institute of Occupational Health and Poison Control, Chinese Center for
Disease Control and Prevention; WHO Collaborating Centre for Occupational Health
JPN-32: Radiation Effects Research Foundation; WHO Collaborating Centre for Researchon Radiation Effects on Humans
JPN-53: University of Occupational & Environmental Health; WHO Collaborating Centre
for Occupational Health
JPN-68: Department of International Health and Radiation, Department of Molecular Biology,
Atomic Bomb Disease Institute, Nagasaki University School of Medicine; WHO Collaborating
Centre for Research on Radiation-induced Thyroid Diseases and Surgical Treatment of Radiation
Injuries
JPN-76: International Centre for Research Promotion and Informatics, National Institute ofOccupational Safety and Health; WHO Collaborating Centre for Occupational Health
JPN-79: Research Center for Radiation Emergency Medicine, National Institute of Radiological
Sciences; WHO Collaborating Centre for Radiation Emergency Medicine

43

•
•
•
•
•

KOR-9: Catholic Industrial Medical Centre, The Catholic University of Korea;
WHO Collaborating Centre for Occupational Health
KOR-86: Occupational Health Department, Korea Occupational Safety and Health Agency;
WHO Collaborating Centre for Occupational Health
SIN-11: Occupational Safety and Health Division, Ministry of Manpower; WHO Collaborating
Centre for Occupational Health
SIN-18: Saw Swee Hock School of Public Health, National University of Singapore;
WHO Collaborating Centre for Occupational Health
VTN-3: National Institute of Occupational & Environmental Health; WHO Collaborating Centre
for Occupational HealthD. International health regulations, emerging diseases and food safety
Facilitator: Mr Peter Hoejskov
Key messages:• Health security and emergency work is central to achieving the SDGs.
• APSED III is an action framework for achieving international health regulations (IHR) corecapacities and managing health security.
• Effective food safety systems build on the risk analysis framework, are well coordinated andpromote learning for continuous improvements.
• WHO CCs play an important role in public health preparedness and response work.
Recommendations:
WHO CCs and WHO agreed to:•increase alignment with the SDGs by:o promoting inclusive monitoring and evaluation;o addressing health inequities in programme development and implementation;o strengthening multisectoral and multi-stakeholder involvement in health security
and food safety work;o supporting health sector leadership for food safety and public health emergency
preparedness and response; and•amplify the effectiveness of WHO work in countries by:o learning from real-world events to emphasize continuous improvement;o building private sector and community involvement through public–private partnerships;
o supporting human resources in the WHO Regional Office Division of Health Security
and Emergencies and WHO CCs, including exchange of technical expertise;o increasing the engagement of WHO CCs in the development and implementation ofnational and regional strategies and frameworks;o increasing the engagement of WHO CCs in the monitoring and evaluation of APSED andfood safety at the country level.
Participating WHO collaborating centres:••

AUS-91: Victorian Infectious Diseases Reference Laboratory, Influenza Reference Laboratory;
WHO Collaborating Centre for Reference and Research on Influenza
AUS-109: Flinders University; WHO Collaborating Centre for Reference and Researchon Influenza

44

•
•
•
•
•
•
•
•
•
•
•
•

CHN-24: China National Center for Food Safety Risk Assessment; WHO Collaborating
Centre for Food Contamination Monitoring
CHN-77: Centre for Disease Control and Prevention of Guangdong Province; WHO Collaborating
Centre for Surveillance, Research and Training of Emerging Infectious Diseases
CHN-91: Centre for Food Safety, Food and Environmental Hygiene Department;
WHO Collaborating Centre for Risk Analysis of Chemicals in Food
CHN-104: Chinese National Influenza Center, National Institute for Viral Disease Control andPrevention, Chinese Center for Disease Control and Prevention; WHO Collaborating Centre for
Reference and Research on Influenza
CHN-122: Health Quarantine and Inspection Department, The General Administration of Quality
Supervision Inspection and Quarantine of the People’s Republic of China; WHO Collaborating
Centre for International Health Regulations: Points of Entry
CHN-126: Institute of Health Quarantine (IHQ), Chinese Academy of Inspection and Quarantine;
WHO Collaborating Centre for International Travel Health
JPN-64: Influenza Virus Research Center, National Institute of Infectious Diseases;
WHO Collaborating Centre for Reference and Research on Influenza
JPN-67: Department of Virology, Institute for Tropical Medicine, Nagasaki University;
WHO Collaborating Centre for Reference and Research on Tropical and Emerging Virus Diseases
JPN-87: Research Centre for Zoonosis Control, Hokkaido University; WHO Collaborating Centre
for Zoonoses Control
JPN-94: Disease Control Prevention Center, National Center For Global Health and Medicine
Hospital; WHO Collaborating Centre for Prevention, Preparedness and Response to Emerging
Infectious Diseases
MAA-12: Tropical Infectious Diseases Research & Education Centre (TIDREC), University of
Malaya; WHO Collaborating Centre for Arbovirus Reference & Research(Dengue/Severe Dengue)
SIN-17: Food Laboratory Health Sciences Authority; WHO Collaborating Centre forFood Contamination Monitoring
E. Library and publications
Facilitator: Ms Marie Villemin-Partow
Key messages:••

The importance of access to authoritative, relevant, impartial and trustworthy sources of
information on health has been recognized in the SDGs. Libraries and publishers are essential
providers of access to health-related information that supports public health outcomes.
Together we can improve the relevance and effectiveness of technical support to countries andWHO staff by providing better services and access to health-related information in all possible
languages.
Recommendations:
WHO CCs and WHO agreed to:••have documents from the regional governing bodies available in Chinese and accessible throughthe Institutional Repository for Information Sharing (IRIS) of the WHO Regional Office for theWestern Pacific; andevaluate and conduct an inventory of all documents published on the website of the WHO
Regional Office for the Western Pacific and propose a model (specifying standard operatingprocedures, review of sources for quality assurance, and process for integration) to have themincluded in the IRIS.

45

Participating WHO collaborating centres:••

CHN-118: People’s Medical Publishing House; WHO Collaborating Centre for Health
Information and Publishing (2 participants)
KOR-99: College of Medicine Library, Seoul National University; WHO Collaborating Centre
for Health information and Library Services (2 participants)

3.2 CROSS-CUTTING THEMATIC GROUP DISCUSSIONS
Cross-cutting thematic discussions were convened to improve participants’ understanding ofpriority cross-cutting themes, their links to the SDGs and their value in improving theeffectiveness of current work plans. Linking traditionally separate areas into existing programmesof work is consistent with the integrated and interrelated nature of the SDG agenda.
These sessions allowed WHO CC participants the opportunity to interact with others from a rangeof technical areas. Participants were encouraged to have at least one takeaway action or message totake back to the final technical session to strengthen their existing work plans.
A. Health promotion in the age of urbanization, migration and ageing
Facilitator: Dr Hai-Rim Shin
Health promotion action works towards improving the conditions of daily life by building healthy
public policies, creating supportive environments, strengthening community action, developing
personal skills and reorienting health services.
Key message:
Health promotion frameworks can strengthen technical support to countries.
Options for strengthening existing WHO CC work plans by incorporating health promotion:•

Green health-care facilities:o Find ways to strengthen attention to health care facilities in rural and developing areas togain full access to water, sanitation and hygiene (WaSH), including as part of barrier-freedevelopment.
o Include tobacco-free and cessation programmes within green HCF initiatives.
o Leverage disability and food safety WHO CCs to generate demand for these aspects as wellas the green HCF menu.

•

NCDs in emergencies in cities:
o Ensure clear lines of communication during emergencies.
o Develop simple, innovative systems for communications.

•

Adolescent health:ooooDevelop campaigns to engage adolescents and young people in health in the Region.
Frame adolescent health needs to be strengths-based, emphasizing the building ofautonomy and resilience.
Focus on supportive environments and settings.
Identify young people as health ambassadors and advocates for young people’s health.

46

•Mental health:o Engage university students and communities.
o Work with media for advocacy and organized reporting of mental health.

• Families Create Health:o Encourage the concept of families to be woven into other campaigns.
o Use different media modalities to cater to a wider age range within families.
B. Achieving universal health coverage: a synergized action addressing equity, quality,
efficiency and financial protection
Facilitators: Dr Rasul Baghirov, Dr Xu Ke
WHO defines UHC as all people having access to quality health services without suffering thefinancial hardship associated with paying for care. UHC is the overarching vision for health sector
development and a key target in SDG3.
Key message:
WHO CCs can support the Regional Office in advancing UHC. UHC work follows the regional
action framework Universal Health Coverage: Moving Towards Better Health, endorsed by the
Regional Committee in 2015.
••

Options for thereby strengthening existing WHO CC work plans by incorporating UHC:
WHO and WHO CCs to explore avenues for joint work in supporting Member States’ efforts in
UHC, particularly in the areas of people-centred care, quality and safety, and cost of essential
health packages.
WHO will keep WHO CCs updated on two fronts:
o further work on clarification of UHC index indicators (definition, collection methods);
ando requests from Member States regarding where WHO CCs can become involved.
C. Health security, including public health preparedness and response to emergencies anddisasters
Facilitator: Dr Frank Konings
The World Health Report 2017 defines health security as the activities required, both proactive andreactive, to minimize vulnerability to acute public health events that endanger the collective healthof national populations. Global public health security similarly relates to the collective health of
populations living across geographic regions and international borders.
Key messages:• The International Health Regulations (IHR) of 2005 are an internationally accepted legal
framework for protecting global health security. In the Western Pacific Region, the Asia PacificStrategy for Emerging Diseases and Public Health Emergencies III (APSED III) is the tool to assist
Member States in achieving IHR core capacities.
• Health security is a cross-cutting issue and is directly related to SDG 3, Target 3.d: “Strengthen thecapacity of all countries, in particular developing countries, for early warning, risk reduction andmanagement of national and global health risks.” It concerns issues beyond infectious diseases,
such as chemical and radio nuclear hazards.

47

•
•
•
•

Options for strengthening existing WHO CC work plans by incorporating health security:
Identify and describe WHO CCs’ strengths in relation to health security.
Engage WHO CCs in IHR joint external evaluation (JEE).
Share information between WHO CCs and WHO for risk assessment.
Strengthen cross-sectoral work, for example, by conducting exercises to create trusting working
relationships.
D. Tackling the social roots of health inequities
Facilitators: Ms Anjana Bhushan, Ms Britta Baer
The SDGs have a strong focus on equity and human rights, informed by the social determinants ofhealth. The integration of equity, human rights, gender and the social determinants of health into
WHO policies, programmes and institutional mechanisms is vital in leaving no one behind, a core
principle of the SDGs.
Key messages:• Equity, gender and rights issues are important concerns in all programme areas and for health in the
broader context. In their interventions, participants illustrated the links between their programme
areas and equity.
• WHO needs to more systematically integrate consideration of equity, gender and rights issues into
its work across all programme areas.
Options for strengthening existing WHO CC work plans by incorporating equity, gender andhuman rights issues:• Identify ways in which equity, gender and rights issues can be more systematically integrated into
WHO CCs’ work, including in their terms of reference during redesignation.
• Since these are cross-cutting issues, they should not be restricted to the activities or efforts of eachindividual WHO CC working with their respective technical programme; rather, ways need to be
identified for WHO CCs to collaborate with one other and with a range of programme areas, forexample, a broader range of WHO CCs can be invited to regional meetings focusing on equity.
E. Public health law: effective use of legislation to support public health policy objectives
Facilitators: Dr Ki Hyun Hahm, Mr Luke ElichLaw is a powerful policy tool that can improve health outcomes and the achievement of the SDGs
in many ways. However, it can be difficult to use effectively. Laws are often developed without
regard to existing evidence and expertise, and not effectively implemented or enforced. Laws canbe poorly designed and ineffective in supporting the underlying policy objective, or haveunintended impacts that are harmful to population health.
Key messages:••

Legislation is effective through changes in attitudes, behaviours and environments. Laws rarely
provide a total solution and cannot work in isolation of the rest of the work we do in health.
Law is not just something that lawyers practice; WHO CCs across a range of programmatic areas
can support countries in the effective use of law to improve health.

•

Options for strengthening existing WHO CC work plans by incorporating health law:
Identify policy and research questions and generate evidence in relation to legislative-based publichealth interventions.
48

•
•

Provide access to comparative experiences and lessons learned to solve policy problems andinform law-making processes.
Undertake strategic planning for legislative reform, advocacy and stakeholder engagement.
F. Antimicrobial resistance: a need for global response to address human and animal healthFacilitators: Dr Babatunde Olowokure, Dr Sarah Paulin
Antimicrobial resistance (AMR) is a complex problem that affects all of society and is driven by
many interconnected factors. Single, isolated interventions have limited impact. Coordinatedaction is required to minimize its emergence and spread.
Key messages:• Actions to combat AMR at the national, regional and global levels are critical for achieving
the 2013 Agenda for Sustainable Development, in particular SDGs 1, 2, 3, 6, 8, 12 and 17.
• Containment of AMR is directly linked to at least seven SDGs; additional advocacy and awarenessraising are needed in this area.
• National multisectoral actions and governance of AMR serve as exemplars forwhole-of-government approaches to achieving the SDGs.
• Several ongoing WHO CC activities contribute to implementation of the five strategic objectivesof the global action plan on AMR, namely, to: (a) improve awareness and understanding of AMR,(b) strengthen knowledge through surveillance research, (c) reduce the incidence of infection, (d) |optimize the use of antimicrobial medicines, and (e) ensure sustainable investment incountering AMR.
•
•
•
•
•
•
•

Options for strengthening existing WHO CC work plans by incorporating AMR:
Continue to communicate via email to strengthen support to countries on AMR, as well as regionaland global initiatives.
Explore potential areas of support to countries on AMR related to existing work plans.
Expand an existing activity already in the work plan related to AMR or add an activity on AMR tofuture work plans related to terms of reference of the WHO CC.
Increase awareness and understanding of AMR.
Strengthen infection prevention and control and waste management in the human and animal
health sectors through assessments and training.
Optimize the use of antimicrobial medicines.
Strengthen evidence-based research on AMR, including the burden of diseases, monitoring
antibiotic use and residue in the animal production pathway, among others.
3.3 CROSS-CUTTING OPERATIONAL GROUP DISCUSSIONS
These sessions were offered to enable the sharing of experiences and expertise in improving theeffectiveness and impact of WHO CC activities in each country. Building on the discussions andconclusions of earlier sessions that focused on what was being implemented, the sessions focusedon how WHO CC–supported activities could be better scoped, designed, implemented andreviewed to be effective in countries. Participants were encouraged to have at least one takeaway
action or message to bring back to the final technical session that would strengthen their existing
work plans.

49

A. Research to support country needs
Facilitators: Dr Gao Jun, Dr David Newby, Dr Noboyuki Nishikiori
Most WHO CCs conduct country support activities such as developing platforms, organizing
meetings to improve the involvement of policy-makers, sharing research results, improving
research capacity, especially for young researchers, and training. Challenges that the WHO CCs
face in improving country support include the need to link their health research agenda to possible
funding sources and donor demands, as well as limited knowledge or connections in countries.
Key messages:• Translating health research into action in countries is challenging but essential for maximizing
the benefits of research.
• Research that is not effectively communicated to decision makers will not realize its potential tosupport health development.
• The collection, analysis and use in policymaking of disaggregated data are core to the SDG agenda,
and baseline data serve as a departure point.
• Regional research priorities are identified during national policy dialogues with governments,
country advisers and academia. Other research emerges from ongoing work, e.g. on
tobacco taxation.
• Setting priorities in mental health research entails linking with the NCD agenda.
• A balance is needed between quantitative research on one hand and qualitative andanthropological research on the other.
• The added value of the WHO research ethics review was discussed in light of the fact that somenational ethics review processes are more robust than WHO’s process and the risk that anotherlayer of review may add a further burden and discourage health research.
Recommendations:
•
•

•
•
•
•

WHO CCs can work with WHO and governments to use disaggregated data and internationallyaccepted definitions.
WHO can help WHO CCs to better engage stakeholders, including policy-makers, providers, thegeneral public and other international experts groups (such as in health policy development) to
identify research gaps and priorities and ensure that research results address country needs. This
may support WHO CCs in accessing competitive research funding.
WHO can work with WHO CCs to develop a platform/research forum that allows WHO CCs,
country offices and other experts to share knowledge that may not be published in scientificpublications, such as documentation on key policy issues and country contexts.
WHO may assist WHO CCs in identifying appropriate funding sources.
WHO may support building capacity in technical and English writing skills to enable local
research to gain international recognition and increase the evidence base within the Region.
WHO’s research ethics review may focus on ensuring that country-specific sensitivities have beenaddressed. A streamlined mechanism may be considered in cases where the institutional- or
national-level ethics review has been sufficiently rigorous.

50

B. Training for impact at country level
Facilitators: Dr Howard Sobel, Ms Elaine O’Leary
Training can be a valuable contributor to health workforce capacity development in countries
when it is determined, designed, implemented and evaluated using a systems approach. While agood training experience is an important starting point, it will not necessarily lead to theapplication of new skills in the workplace in the absence of complementary strategies.
Key messages:• WHO-led training is best embedded in a health systems approach.
• The objectives of training should go beyond transferring knowledge; training should havepractical and sustainable outcomes.
• WHO CCs can work more closely with WHO by being more aware of norms and standards
and contexts in the Member States.
Recommendations:
•
•
•
•
•

Consider factors such as the system, align with national policies, cultural differences and existing
capacity in determining if and what kind of training is appropriate.
Involve partner country stakeholders in designing the training programme.
Design training for sustainable outcomes and behavioural change.
Consider follow-up mentoring and other supports for sustainability and ensuring that learnings areapplied.
Develop an assessment tool for short- and long-term trainings.
C. Communicating for better results
Facilitators: Dr Angela Pratt, Mr Eloi Yao
Communications can be a powerful tool for improving the effectiveness of activities. It can build
support for health development, foster advocates for reform, galvanize support and encourage
more informed decision making at all levels. Communications should therefore be an integral partof the planning of any initiative, rather than a process that is undertaken at the end of an activity.
Key messages:• Advocacy informs and motivates leadership to create a supportive environment to achieve
programme objectives and development goals.
• Social mobilization engages and supports participation of institutions, community networks andsocial/civic groups to raise demand for or sustain progress toward development objectives.
• Behaviour change communication involves face-to-face dialogue with individuals or groups toinform, motivate, problem-solve or plan, with the objective to promote and sustain
behaviour change.
Recommendations:••••

Identify the communication goals that may help shape the overall project objectives; also identify
the audiences and the tools to be used in the planning process.
Ensure proper communication lines are established and used correctly throughout theimplementation cycle.
Establish schedules for continuous communication with stakeholders and audiences.
Make strategic use of a combination of tools.

51

•
•
•

Allocate resources (both human and financial) properly according to agreed-upon priorities.
Seek feedback and use them constructively to improve communication effectiveness.
Establish evaluation mechanisms to assess impact.

52

ANNEX 4

Second Regional Forum of WHO Collaborating Centres in the Western PacificMonday | 28 November, 12:45–1:30pm

POSTER SESSION 1
Moderator:

12:50 PM

12:55 PM

1:00 PM

1:05 PM

1:10 PM

1:15 PM

1:20 PM

Upper Lounge

Foyer

Conference Hall

Conference Hall

Conference Hall

Nagai Mari
CHN-2912:45 PM

Lower Lounge

MCA

Naoko Ishikawa
JPN-93

EPI

Uhjin Kim, Sarah
PaulinSIN-28HII

Research in Human
Reproduction

Virus Reference andResearch(Enteroviruses)

Bioethics

CHN-56

AUS-121

KOR-96MCA

HSI

Yu Lee Park
AUS-86

HPF

CHN-30Research in Human
Reproduction

Viral Hepatitis

Health Law andBioethics

Traditional
Medicine

CHN-63

AUS-72

CHN-19CHN-32

MCA

HSI

EMT

Research in Human
Reproduction

Sexually Transmitted
Diseases

Drug Quality
Assurance

Traditional
Medicine

CHN-74

AUS-89

SIN-25

CHN-33

MCA

HSI

EMT

R&T in Women's andChildren's Health

Capacity Building and
HCW Training in
HIV/AIDS

Medicines Quality
Assurance

Traditional
Medicine

JPN-61

CHN-92

MAA-15

CHN-34

MCA

HSI

EMT

Maternal and Child
HealthComprehensive
Management of HIV
treatment and care

Regulatory Control of
Pharmaceuticals

Traditional
Medicine

CHN-65

JPN-38

JPN-28

MCA

STB

EMT

Research in Reproductive Reference, R&T on
Health and Population
Tuberculosis
ScienceStandardization and
Evaluation of
Biologicals

JPN-78

KOR-90MCA

KOR-24STB

ISD

Traditional
Medicine

ISD

ISD

ISD

ISD

Mina Kashiwabara
JPN-83

NCD

Rasul Baghirov or
Indrajit Hazarika
KOR-98HPF

May Chiew
CHN-122ESR

HAE

Health System and
Financing

IHR: Points of Entry

Environmental Health andPrevention of Chemical
Hazards

CHN-113

JPN-45

CHN-126

AUS-78TFI

ISD

Smoking Cessation andTreatment of Tobacco
Dependence

Health Systems
Research

CHN-119

KOR-19

TFI

ISD

ESR

HAE

International Travel Health

Environmental Health Impact
Assessment

AUS-109

KOR-97ESR

HAE

Tobacco and Economics

Health Systems
Research

Mass Gatherings and HighVisibility/High
Consequence Events

Vulnerable Population andEnvironment Health

JPN-90

KOR-102

CHN-77

JPN-49TFI

Tobacco Testing andResearch

Educational
Development

SIN-22

MAA-14TFI

Tobacco Testing andResearch

ISD

ISD

ESR

HAE

Surveillance, Research andTraining of EID

Studies on the Health Effects
of Mercury Compounds

JPN-94

JPN-79ESR

HAE

Health Systems
Research and Quality
Improvement

Prevention, Preparedness
and Response to EID

Radiation Emergency
Medicine

CHN-115 ISD

AUS-92

CHN-24

JPN-32

Traditional
MedicineeHealthEMT

CHN-118

HII

IPS

FOS

WHO Collaborating Centre
for Research on Radiation
Effects on Humans

SIN-17

JPN-68FOS

Health Information andPublishing

Food Contamination
Monitoring

AUS-93

CHN-55

JPN-85

JPN-77

ISD

Blood Transfusion
Services

HII

Family of International
Classifications

53

HAE

Food Contamination
Monitoring

Standardization andevaluation of
biologicals

ISD

JPN-91Prevention and Control
of Chronic Respiratory
Diseases

R&T in Population ,R&T and Reference
Reproductive Health and Laboratory on
Development
Tuberculosis

Nursing, Midwifery and
Health Development

Hassan Nasir

ISD

Nursing in Disasters and
Health Emergency
Management

HAE

Research on RadiationInduced Thyroid Diseases
and Surgical Treatment ofRadiation Injuries

Second Regional Forum of WHO Collaborating Centres in the Western Pacific
Tuesday | 29 November, 1:00pm–1:45pm

POSTER SESSION 2
Moderator:

1:05 PM

1:10 PM

1:15 PM

1:20 PM

1:25 PM

1:30 PM

Upper Lounge

Foyer

Conference Hall

Conference Hall

Conference Hall

Xiao Sobel
AUS-771:00 PM

Lower Lounge

MHS

Darryl Barrett

ESR

AUS-110

Population Salt Reduction

Reference and Researchon Influenza

Tropical Disease

Healthy Cities and Urban
Policy Research

CHN-47

CHN-104

CHN-58

JPN-51MVP

NCD

JPN-54 ISD

SIN-11 HAE

SIN-21

Traditional
Medicine

Occupational
HealthHealth Promotion and
Disease Prevention

Reference and Researchon Influenza

Schistosomiasis Control in
Lake Regions

Community Water
Supply and Sanitation

JPN-57

JPN-64

AUS-68

JPN-50BPC

KOR-17 ISD

SIN-18 HAE

CHN-91Prevention of Blindness

Traditional
Medicine

Occupational
HealthRisk Analysis of Chemicals
in Food

Reference and Researchon Influenza

Control of LF, STH and other
NTDs

Integrated PeopleCentred Service Delivery

JPN-92

CHN-88

MAA-12

PHL-19JPN-58

JPN-53 HAE

AUS 80

Traditional
Medicine

Occupational
HealthObesity Prevention

Arbovirus Reference &Research (Dengue / Severe
Dengue)Malaria Diagnosis

Nursing Development inPrimary Health Care

AUS-85

JPN-70

KOR-89 ISD

KOR-9 HAE

AUS-107

SIN-26

CHN-136

JPN-89

Occupational
HealthPhysical Activity, Nutrition
and Obesity

Reference and Research of
Arbovirus and AssociatedVectors

R&T on Malaria Elimination

R&T on Interprofessional Education

CHN-120

CHN-76

JPN-75

MVP

MVP

ISD

KOR-18 ISD

NCD

ESR

MVP

Prevention andRehabilitation of Hearing
Impairment

DAR

NUT

ESR

R&T in Suicide Prevention

VIP

BPC

FOS

HAE

R&T on Alcohol-Related
Problems

MHS

JPN-34MVP

JPN-73

R&T in Child Mental Health Prevention of Deafness

MHS

ESR

CHN-130

Indrajit Hazarika

Occupational
HealthNCD

AUS-91

Rabi Abeyasinghe

JPN-76 HAE

BPC

NCD

Frank Konings

Traditional
Medicine

MVP

ISD

ISD

Violence, Injuries andDisabilities

Disability Prevention andRehabilitation

Traditional
Medicine

KOR-104

AUS-113

JPN-46 ISD

JPN-88

Traditional
Medicine

Nutrition and Physical
Activity

Infectious Disease
Epidemiology and Control

Gene Synthesis and Expression

Translation of Oral
Health Science

JPN-56

JPN-67

CHN-114

PHL-13NCD

DAR

Training in Hospice &Palliative Care

Health Workforce
Development inRehabilitation and Long
Term Care

CHN-89CHN-50MCA

Community HealthServices

DAR

Rehabilitation

CHN-60
1:35 PM

Katrin Engelhardt

CHN-35 ISD

CHN-94

BPC

Hassan Nasir

R&T and Consultative Work Prevention of Blindness
on Mental Health

MHS

AUS-59

Yu Lee Park

DAR

Training and Research in
Rehabilitation

NUT

NCD

ISD

ESR

Diabetes Treatment and
Education

Reference and Researchon Tropical and Emerging
Virus Diseases

KOR-84

JPN-87

NCD

Cancer Registration,
Prevention and Early
Detection

54

ESR

Zoonoses Control

MVP

MVP

Vector Surveillance andManagement

NCD

ISD

Leadership in Nursing
Development

CHN-129

ISD

Nursing Policy-Making
and Leadershipwww.wpro.who.int